Nuveen Churchill Private Capital Income Fund 10-Q 1 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 01, 2023
Class of Stock [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Securities Act File Number	001-04321
Entity Registrant Name	NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-6187397
Entity Address, Address Line One	375 Park Avenue, 9th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10152
City Area Code	212
Local Phone Number	478-9200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001911066
Amendment Flag	false
Class I Common Shares
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		12,975,926
Class D Common Shares
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		7,111
Class S Common Shares
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		40,634
Former Address
Class of Stock [Line Items]
Entity Address, Address Line One	430 Park Avenue, 14th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022

CONSOLIDATED STATEMENTS OF ASSE

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $451,244 and $352,998, respectively)	$ 451,194	$ 349,518
Cash and cash equivalents	6,344	65,785
Due from affiliate expense support (See Note 4)	2,853	2,215
Interest receivable	5,594	4,282
Receivable for investments sold	1,011	196
Prepaid expenses	71	29
Total assets	461,650	422,025
Liabilities
Secured borrowings (net of $551 and $647 deferred financing costs, respectively) (See Note 5)	120,199	154,353
Distributions payable	3,070	3,109
Payable for investments purchased	29,747	0
Interest payable	446	533
Due to affiliate expense support (See Note 4)	2,853	2,215
Board of Trustees' fees payable	128	128
Accounts payable and accrued expenses	1,924	1,386
Due to transfer agent	1,145	0
Total liabilities	159,512	161,724
Commitments and contingencies (See Note 6)
Net Assets: (See Note 7)
Common shares of beneficial interest, par value $0.01 per share, unlimited shares authorized, 12,279,387 and 10,540,040 Class I shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	123	105
Paid-in-capital in excess of par value	306,173	263,396
Total distributable earnings (loss)	(4,158)	(3,200)
Total net assets	302,138	260,301
Total liabilities and net assets	$ 461,650	$ 422,025
Net asset value per Class I share (in dollars per share)	$ 24.61	$ 24.70
Non-controlled/Non-affiliated
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $451,244 and $352,998, respectively)	$ 445,777	$ 349,518

CONSOLIDATED STATEMENTS OF AS_2

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Amortized cost	$ 456,661	$ 352,998
Deferred financing costs	$ 551	$ 647
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares outstanding (in shares)	12,279,386
Class I Common Shares
Common shares, shares issued (in shares)	12,279,387	10,540,040
Common shares, shares outstanding (in shares)	12,279,387	10,540,040
Non-controlled/Non-affiliated
Amortized cost	$ 451,244	$ 352,998

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023
Investment income:
Payment-in-kind interest income	$ 573,000	$ 211,000	$ 450,000		$ 1,647,000
Dividend income	17,000	0	0		115,000
Other income	100,000	446,000	446,000		131,000
Expenses:
Organizational expenses	0	148,000	1,081,000	[1]	0
Interest and debt financing expenses	2,637,000	1,325,000	1,892,000	[1]	7,711,000
Interest expense on Note (See Note 4)	0	0	226,000	[1]	0
Professional fees	250,000	291,000	742,000	[1]	665,000
Management fees	547,000	0	0	[1]	712,000
Income based incentive fees	1,219,000	0	0	[1]	1,592,000
Board of Trustees’ fees	128,000	128,000	257,000	[1]	380,000
Administration fees	124,000	74,000	149,000	[1]	362,000
Other general and administrative expenses	326,000	71,000	129,000	[1]	588,000
Offering costs	187,000	78,000	118,000	[1]	468,000
Total expenses	5,418,000	2,115,000	4,594,000	[1]	12,478,000
Expense support	(212,000)	(245,000)	(1,422,000)	[1]	(541,000)
Management fees waived (Note 4)	(547,000)	0	0	[1]	(712,000)
Incentive fees waived (Note 4)	(1,219,000)	0	0	[1]	(1,592,000)
Net expenses	3,440,000	1,870,000	3,172,000	[1]	9,633,000
Net investment income (loss)	8,746,000	5,342,000	10,416,000	[2]	23,931,000
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments			(264,000)	[3]	685,000
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments			(2,262,000)	[3]	(1,987,000)
Net increase (decrease) in net assets resulting from operations	$ 9,065,000	$ 4,088,000	$ 7,890,000	[2]	$ 22,629,000
Per share data:
Net investment income per share - basic (in dollars per share)	$ 0.75	$ 0.51	$ 0.99	[1]	$ 2.18
Net investment income per share - diluted (in dollars per share)	0.75	0.51	0.99	[1]	2.18
Net increase (decrease) in net assets resulting from operations per share (in dollars per share)	$ 0.78	$ 0.39	$ 0.75	[1]	$ 2.06
Weighted average common shares outstanding - basic (in shares)	11,758,707	10,540,040	10,483,067	[1]	10,985,133
Weighted average common shares outstanding - diluted (in shares)	11,758,707	10,540,040	10,483,067	[1]	10,985,133
Non-controlled/Non-affiliated
Investment income:
Interest income	$ 11,496,000	$ 6,555,000	$ 12,692,000	[1]	$ 31,671,000
Payment-in-kind interest income	573,000	211,000	450,000	[1]	1,647,000
Dividend income	17,000	0	0	[1]	115,000
Other income	100,000	446,000	446,000	[1]	131,000
Total investment income	12,186,000	7,212,000	13,588,000	[1]	33,564,000
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	67,000	3,000	(264,000)	[1]	685,000
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments	252,000	(1,257,000)	(2,262,000)	[1]	(1,987,000)
Total net realized and unrealized gain (loss) on investments	$ 319,000	$ (1,254,000)	$ (2,526,000)	[1]	$ (1,302,000)
[1]Period from February 8, 2022 (inception) through September 30, 2022.[2]Period from February 8, 2022 (inception) through September 30, 2022.[3]Period from February 8, 2022 (inception) through September 30, 2022.

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended			8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022		Sep. 30, 2022		Sep. 30, 2023	Sep. 30, 2022	[1]
Increase (decrease) in net assets resulting from operations:
Net investment income (loss)	$ 8,746	$ 5,342		$ 10,416	[1]	$ 23,931
Net realized gain (loss) on investments	67	3		(264)	[1]	685
Net change in unrealized appreciation (depreciation) on investments	252	(1,257)		(2,262)	[1]	(1,987)
Net increase (decrease) in net assets resulting from operations	9,065	4,088		7,890	[1]	22,629
Shareholder Distributions:
Distribution declared from net investment income	(8,823)	(9,170)		(9,170)	[1]	(23,128)
Distribution declared from realized gains	(460)	0		0		(460)
Net increase (decrease) in net assets resulting from shareholder distributions	(9,283)	(9,170)		(9,170)	[1]	(23,588)
Capital share transactions:
Issuance of common shares, net	34,970	0		263,501	[1]	42,690
Reinvestment of shareholder distributions	106	0				106	$ 0
Net increase (decrease) in net assets resulting from capital share transactions - Class I	35,076	0		263,501	[1]	42,796
Total increase (decrease) in net assets	34,858	(5,082)		262,221	[1]	41,837
Net assets, at beginning of period	267,280	267,303		0	[1]	260,301
Net assets, at end of period	$ 302,138	$ 262,221	[1]	$ 262,221	[1]	$ 302,138	$ 262,221
[1]Period from February 8, 2022 (inception) through September 30, 2022.

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	8 Months Ended		9 Months Ended
	Sep. 30, 2022		Sep. 30, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 7,890	[1]	$ 22,629
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments	(55,661)	[2]	(120,285)
Proceeds from principal repayments and sales of investments	27,692	[2]	24,852
Payment-in-kind interest	(450)	[2]	(1,647)
Amortization of premium/accretion of discount, net	(325)	[2]	(607)
Net realized (gain) loss on investments	264	[2]	(685)
Net change in unrealized (appreciation) depreciation on investments	2,262	[2]	1,987
Amortization of deferred financing costs	0	[2]	122
Changes in operating assets and liabilities:
Due from affiliate expense support	(2,039)	[2]	(638)
Receivable for investments sold	(209)	[2]	(815)
Interest receivable	(4,640)	[2]	(1,186)
Prepaid expenses	(50)	[2]	(42)
Payable for investments purchased	0	[2]	29,747
Interest payable	287	[2]	(87)
Due to affiliate expense support	2,039	[2]	638
Board of Trustees' fees payable	128	[2]	0
Accounts payable and accrued expenses	720	[2]	538
Due to transfer agent	0	[2]	1,145
Net cash provided by (used in) operating activities	(22,092)	[2]	(44,334)
Cash flows from financing activities:
Proceeds from issuance of common shares	1	[2]	42,690
Proceeds from secured borrowings	125,000	[2]	54,250
Repayments of secured borrowings	(32,731)	[2]	(88,500)
Distributions paid	0	[2]	(23,521)
Payments of deferred financing costs	0	[2]	(26)
Net cash provided by (used in) financing activities	92,270	[2]	(15,107)
Net increase (decrease) in cash and cash equivalents	70,178	[2]	(59,441)
Cash and cash equivalents, beginning of period	0	[2]	65,785
Cash and cash equivalents, end of period	70,178	[2]	6,344
Supplemental information and non-cash activities:
Purchases of investments	(296,231)	[2]	0
Cash paid during the period for interest	1,796	[2]	7,676
Financing costs paid through expense support	373	[2]	0
Cash paid during the period for excise taxes	0	[2]	2
Issuance of Class I common shares, net	263,500	[2]	0
Reinvestment of Shareholder Distributions	$ 0	[2]	$ 106
[1]Period from February 8, 2022 (inception) through September 30, 2022.[2]Period from February 8, 2022 (inception) through September 30, 2022.

CONSOLIDATED SCHEDULE OF INVEST

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands		Sep. 30, 2023		Dec. 31, 2022
Schedule of Investments [Line Items]
Cost		$ 456,661		$ 352,998
Fair Value		$ 451,194		$ 349,518
% of Net Assets		149.33%	[1]	134.27%	[2]
Debt Securities
Schedule of Investments [Line Items]
Cost		$ 442,457		$ 349,421
Fair Value		$ 436,449		$ 345,180
% of Net Assets		144.45%	[1]	132.60%	[2]
Equity Investments
Schedule of Investments [Line Items]
Cost		$ 8,787		$ 3,577
Fair Value		$ 9,328		$ 4,338
% of Net Assets		3.09%	[1]	1.67%	[2]
Cash Equivalents
Schedule of Investments [Line Items]
Cost	[3]	$ 5,417
Fair Value	[3]	$ 5,417
% of Net Assets	[1],[3]	1.79%
Aerospace & Defense | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 1,928
Fair Value		$ 1,929
% of Net Assets	[1]	0.64%
Aerospace & Defense | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,180
Fair Value		$ 1,180
% of Net Assets	[1]	0.39%
Automotive | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 4,899		$ 3,918
Fair Value		$ 4,897		$ 3,893
% of Net Assets		1.62%	[1]	1.50%	[2]
Banking, Finance, Insurance, Real Estate | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 4,839		$ 375
Fair Value		$ 4,725		$ 266
% of Net Assets		1.56%	[1]	0.10%	[2]
Beverage, Food & Tobacco | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 43,217		$ 43,357
Fair Value		$ 42,844		$ 43,015
% of Net Assets		14.18%	[1]	16.53%	[2]
Beverage, Food & Tobacco | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 980		$ 681
Fair Value		$ 1,194		$ 831
% of Net Assets		0.40%	[1]	0.32%	[2]
Capital Equipment | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 17,298		$ 6,891
Fair Value		$ 17,282		$ 6,937
% of Net Assets		5.72%	[1]	2.66%	[2]
Capital Equipment | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 160
Fair Value		$ 181
% of Net Assets	[1]	0.06%
Chemicals, Plastics, & Rubber | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 18,329		$ 14,083
Fair Value		$ 17,698		$ 13,976
% of Net Assets		5.86%	[1]	5.37%	[2]
Chemicals, Plastics, & Rubber | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 504		$ 504
Fair Value		$ 812		$ 980
% of Net Assets		0.27%	[1]	0.38%	[2]
Construction & Building | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 21,332		$ 15,713
Fair Value		$ 21,251		$ 15,568
% of Net Assets		7.03%	[1]	5.98%	[2]
Construction & Building | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 330		$ 212
Fair Value		$ 337		$ 219
% of Net Assets		0.11%	[1]	0.08%	[2]
Consumer Goods: Durable | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 19,105		$ 15,875
Fair Value		$ 18,837		$ 15,653
% of Net Assets		6.23%	[1]	6.01%	[2]
Consumer Goods: Non-Durable | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 28,953		$ 26,344
Fair Value		$ 28,801		$ 26,157
% of Net Assets		9.53%	[1]	10.05%	[2]
Consumer Goods: Non-Durable | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 763		$ 228
Fair Value		$ 823		$ 263
% of Net Assets		0.27%	[1]	0.10%	[2]
Containers, Packaging & Glass | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 16,373		$ 16,335
Fair Value		$ 16,343		$ 16,303
% of Net Assets		5.41%	[1]	6.26%	[2]
Containers, Packaging & Glass | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 780		$ 719
Fair Value		$ 663		$ 774
% of Net Assets		0.22%	[1]	0.30%	[2]
Energy: Electricity | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 499
Fair Value		$ 497
% of Net Assets	[1]	0.16%
Energy: Oil & Gas | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 22,822		$ 21,951
Fair Value		$ 22,053		$ 21,275
% of Net Assets		7.30%	[1]	8.17%	[2]
Environmental Industries | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 14,857		$ 7,734
Fair Value		$ 14,713		$ 7,661
% of Net Assets		4.87%	[1]	2.94%	[2]
Healthcare & Pharmaceuticals | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 34,080		$ 25,919
Fair Value		$ 33,664		$ 25,541
% of Net Assets		11.14%	[1]	9.81%	[2]
Healthcare & Pharmaceuticals | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 162
Fair Value		$ 179
% of Net Assets	[1]	0.06%
High Tech Industries | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 17,353		$ 9,449
Fair Value		$ 17,351		$ 9,414
% of Net Assets		5.74%	[1]	3.62%	[2]
High Tech Industries | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 119		$ 119
Fair Value		$ 237		$ 158
% of Net Assets		0.08%	[1]	0.06%	[2]
Hotel, Gaming & Leisure | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 1,249
Fair Value		$ 1,250
% of Net Assets	[1]	0.41%
Media: Advertising, Printing & Publishing | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 6,860		$ 6,906
Fair Value		$ 6,867		$ 6,916
% of Net Assets		2.27%	[1]	2.66%	[2]
Media: Broadcasting & Subscription | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 3,110
Fair Value		$ 3,095
% of Net Assets	[1]	1.02%
Metals and Mining | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 503
Fair Value		$ 500
% of Net Assets	[1]	0.17%
Services: Business | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 76,024		$ 59,479
Fair Value		$ 74,338		$ 58,583
% of Net Assets		24.60%	[1]	22.51%	[2]
Services: Business | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 2,057		$ 865
Fair Value		$ 1,889		$ 782
% of Net Assets		0.63%	[1]	0.30%	[2]
Services: Consumer | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 32,736		$ 23,623
Fair Value		$ 32,037		$ 23,088
% of Net Assets		10.60%	[1]	8.87%	[2]
Services: Consumer | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,396		$ 142
Fair Value		$ 1,352		$ 151
% of Net Assets		0.45%	[1]	0.06%	[2]
Sovereign & Public Finance | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 3,602		$ 3,617
Fair Value		$ 3,671		$ 3,607
% of Net Assets		1.22%	[1]	1.39%	[2]
Sovereign & Public Finance | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 107		$ 107
Fair Value		$ 217		$ 180
% of Net Assets		0.07%	[1]	0.07%	[2]
Telecommunications | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 7,844		$ 6,894
Fair Value		$ 7,403		$ 6,720
% of Net Assets		2.45%	[1]	2.58%	[2]
Transportation: Cargo | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 11,599		$ 10,902
Fair Value		$ 11,620		$ 10,901
% of Net Assets		3.85%	[1]	4.18%	[2]
Transportation: Consumer | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,816
Fair Value		$ 2,812
% of Net Assets	[1]	0.94%
Transportation: Consumer | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 137
Fair Value		$ 161
% of Net Assets	[1]	0.05%
Utilities: Electric | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,477
Fair Value		$ 2,465
% of Net Assets	[1]	0.82%
Utilities: Electric | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 112
Fair Value		$ 103
% of Net Assets	[1]	0.03%
Wholesale | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 27,753		$ 30,056
Fair Value		$ 27,506		$ 29,706
% of Net Assets		9.11%	[1]	11.41%	[2]
Investment, Identifier [Axis]: A Place for Mom, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[4],[5],[6]	4.50%	[7],[8],[9],[10]
Interest Rate		9.82%	[4],[5],[6]	9.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,872	[4],[5]	$ 6,936	[7],[8],[9]
Cost		6,872	[4],[5]	6,936	[7],[8],[9]
Fair Value		$ 6,748	[4],[5]	$ 6,657	[7],[8],[9]
% of Net Assets		2.23%	[1],[4],[5]	2.56%	[2],[7],[8],[9]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6%	[4],[5],[6],[11]	6%	[7],[8],[9],[10]
Interest Rate		11.47%	[4],[5],[6],[11]	10.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 4,953	[4],[5],[11]	$ 4,848	[7],[8],[9]
Cost		4,915	[4],[5],[11]	4,807	[7],[8],[9]
Fair Value		$ 4,634	[4],[5],[11]	$ 4,800	[7],[8],[9]
% of Net Assets		1.53%	[1],[4],[5],[11]	1.84%	[2],[7],[8],[9]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6%	[4],[5],[6],[11],[12]	6%	[7],[8],[9],[10],[13]
Interest Rate		11.47%	[4],[5],[6],[11],[12]	10.59%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 1,000	[4],[5],[11],[12]	$ 1,000	[7],[8],[9],[13]
Cost		0	[4],[5],[11],[12]	0	[7],[8],[9],[13]
Fair Value		$ (64)	[4],[5],[11],[12]	$ (10)	[7],[8],[9],[13]
% of Net Assets		(0.02%)	[1],[4],[5],[11],[12]	0%	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6%	[4],[5],[6],[11],[12]	6%	[7],[8],[9],[10],[13]
Interest Rate		11.47%	[4],[5],[6],[11],[12]	10.59%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 920	[4],[5],[11],[12]	$ 150	[7],[8],[9],[13]
Cost		0	[4],[5],[11],[12]	0	[7],[8],[9],[13]
Fair Value		$ (59)	[4],[5],[11],[12]	$ (1)	[7],[8],[9],[13]
% of Net Assets		(0.02%)	[1],[4],[5],[11],[12]	0%	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[9],[10],[13]			6%
Interest Rate	[7],[8],[9],[10],[13]			10.59%
Par Amount / Unit	[7],[8],[9],[13]			$ 1,000
Cost	[7],[8],[9],[13]			0
Fair Value	[7],[8],[9],[13]			$ (10)
% of Net Assets	[2],[7],[8],[9],[13]			0%
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 142	[5],[16],[17]	$ 142	[8],[14],[15]
Fair Value		$ 91	[5],[16],[17]	$ 151	[8],[14],[15]
% of Net Assets		0.03%	[1],[5],[16],[17]	0.06%	[2],[8],[14],[15]
Share / Unit		1,419	[5],[16],[17]	1	[8],[14],[15]
Investment, Identifier [Axis]: ALKU Intermediate Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.57%
Par Amount / Unit	[4],[5]	$ 2,718
Cost	[4],[5]	2,665
Fair Value	[4],[5]	$ 2,667
% of Net Assets	[1],[4],[5]	0.88%
Investment, Identifier [Axis]: AMC Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[10]			5.50%
Interest Rate	[7],[8],[10]			10.09%
Par Amount / Unit	[7],[8]			$ 6,947
Cost	[7],[8]			6,919
Fair Value	[7],[8]			$ 6,947
% of Net Assets	[2],[7],[8]			2.67%
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 137
Fair Value	[5],[16],[17]	$ 161
% of Net Assets	[1],[5],[16],[17]	0.05%
Share / Unit	[5],[16],[17]	160,609
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.65%
Par Amount / Unit	[4],[5]	$ 2,221
Cost	[4],[5]	2,178
Fair Value	[4],[5]	$ 2,179
% of Net Assets	[1],[4],[5]	0.72%
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.65%
Par Amount / Unit	[4],[5],[12]	$ 891
Cost	[4],[5],[12]	(4)
Fair Value	[4],[5],[12]	$ (17)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Accupac, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		6%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		11.40%	[4],[5],[6],[11]	10.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,893	[4],[5],[11]	$ 6,946	[7],[8],[9]
Cost		6,876	[4],[5],[11]	6,923	[7],[8],[9]
Fair Value		$ 6,666	[4],[5],[11]	$ 6,815	[7],[8],[9]
% of Net Assets		2.21%	[1],[4],[5],[11]	2.62%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Adient US LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.25%
Interest Rate	[4],[6],[18],[19]	8.65%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	503
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Air Canada
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.50%
Interest Rate	[4],[6],[18],[19]	8.90%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: AmSpec Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11]	5.75%	[7],[8],[9],[10]
Interest Rate		11.15%	[4],[5],[6],[11]	10.52%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,891	[4],[5],[11]	$ 6,946	[7],[8],[9]
Cost		6,891	[4],[5],[11]	6,946	[7],[8],[9]
Fair Value		$ 6,891	[4],[5],[11]	$ 6,945	[7],[8],[9]
% of Net Assets		2.28%	[1],[4],[5],[11]	2.67%	[2],[7],[8],[9]
Investment, Identifier [Axis]: American Student Transportaton Partners, Inc
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10%
Interest Rate, PIK	[5],[6]	3.50%
Par Amount / Unit	[5]	$ 1,606
Cost	[5]	1,562
Fair Value	[5]	$ 1,562
% of Net Assets	[1],[5]	0.52%
Investment, Identifier [Axis]: Apex Services Partners, LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	10.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 2,978	[4],[5],[11]	$ 3,000	[7],[8],[9]
Cost		2,968	[4],[5],[11]	2,987	[7],[8],[9]
Fair Value		$ 2,977	[4],[5],[11]	$ 2,981	[7],[8],[9]
% of Net Assets		0.99%	[1],[4],[5],[11]	1.14%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Apex Services Partners, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	10.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 2,978	[4],[5],[11]	$ 3,000	[7],[8],[9]
Cost		2,958	[4],[5],[11]	2,973	[7],[8],[9]
Fair Value		$ 2,977	[4],[5],[11]	$ 2,981	[7],[8],[9]
% of Net Assets		0.99%	[1],[4],[5],[11]	1.14%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Arise Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.25%	[4],[5],[6]	4.25%	[7],[8],[10]
Interest Rate		9.72%	[4],[5],[6]	8.84%	[7],[8],[10]
Par Amount / Unit		$ 6,893	[4],[5]	$ 6,946	[7],[8]
Cost		6,853	[4],[5]	6,894	[7],[8]
Fair Value		$ 6,414	[4],[5]	$ 6,720	[7],[8]
% of Net Assets		2.12%	[1],[4],[5]	2.58%	[2],[7],[8]
Investment, Identifier [Axis]: Arsenal AIC Parent LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	4.50%
Interest Rate	[4],[6],[18]	9.90%
Par Amount / Unit	[4],[18]	$ 500
Cost	[4],[18]	503
Fair Value	[4],[18]	$ 500
% of Net Assets	[1],[4],[18]	0.17%
Investment, Identifier [Axis]: BPC Kodiak LLC (Turbine Engine Specialist, Inc) LLC Intrest
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[20]	$ 1,180
Fair Value	[5],[16],[17],[20]	$ 1,180
% of Net Assets	[1],[5],[16],[17],[20]	0.39%
Share / Unit	[5],[16],[17],[20]	1,180,000
Investment, Identifier [Axis]: Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[19],[21]	6.25%
Interest Rate	[4],[5],[6],[19],[21]	11.65%
Par Amount / Unit	[4],[5],[19],[21]	$ 4,246
Cost	[4],[5],[19],[21]	4,162
Fair Value	[4],[5],[19],[21]	$ 4,162
% of Net Assets	[1],[4],[5],[19],[21]	1.38%
Investment, Identifier [Axis]: Belron Finance US LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.43%
Interest Rate	[4],[6],[18],[19]	7.82%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10]			10%
Interest Rate, PIK	[8],[10]			3.75%
Par Amount / Unit		$ 2,673	[5]	$ 2,649	[8]
Cost		2,627	[5]	2,597	[8]
Fair Value		$ 2,580	[5]	$ 2,598	[8]
% of Net Assets		0.85%	[1],[5]	1%	[2],[8]
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 655	[5],[16],[17]	$ 655	[8],[14],[15]
Fair Value		$ 600	[5],[16],[17]	$ 655	[8],[14],[15]
% of Net Assets		0.20%	[1],[5],[16],[17]	0.25%	[2],[8],[14],[15]
Share / Unit		43,679	[5],[16],[17]	44	[8],[14],[15]
Investment, Identifier [Axis]: Brown & Joseph, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.75%	[7],[8],[10]
Interest Rate		10.82%	[4],[5],[6]	10.34%	[7],[8],[10]
Par Amount / Unit		$ 6,639	[4],[5]	$ 6,945	[7],[8]
Cost		6,602	[4],[5]	6,896	[7],[8]
Fair Value		$ 6,639	[4],[5]	$ 6,920	[7],[8]
% of Net Assets	[2]	2.20%	[4],[5]	2.66%	[7],[8]
Investment, Identifier [Axis]: CDI AcquisitionCo, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4%	[4],[5],[6]	4.50%	[7],[8],[10]
Interest Rate		9.47%	[4],[5],[6]	9.28%	[7],[8],[10]
Par Amount / Unit		$ 6,729	[4],[5]	$ 6,865	[7],[8]
Cost		6,714	[4],[5]	6,840	[7],[8]
Fair Value		$ 6,729	[4],[5]	$ 6,827	[7],[8]
% of Net Assets		2.22%	[1],[4],[5]	2.62%	[2],[7],[8]
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc.
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	9%
Interest Rate, PIK	[5],[6]	4%
Par Amount / Unit	[5]	$ 642
Cost	[5]	625
Fair Value	[5]	$ 625
% of Net Assets	[1],[5]	0.21%
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate	[5],[6],[12]	9%
Interest Rate, PIK	[5],[6],[12]	4%
Par Amount / Unit	[5],[12]	$ 503
Cost	[5],[12]	(7)
Fair Value	[5],[12]	$ (14)
% of Net Assets	[1],[5],[12]	0%
Investment, Identifier [Axis]: COP Exterminators Investment, LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 862
Fair Value	[5],[16],[17]	$ 862
% of Net Assets	[1],[5],[16],[17]	0.29%
Share / Unit	[5],[16],[17]	770,000
Investment, Identifier [Axis]: CV Holdco, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost	[8],[14],[15]			$ 102
Fair Value	[8],[14],[15]			$ 49
% of Net Assets	[2],[8],[14],[15]			0.02%
Share / Unit	[8],[14],[15]			1
Investment, Identifier [Axis]: CV Intermediate Holdco Corp.
Schedule of Investments [Line Items]
Interest Rate		11%	[5],[6]	11%	[8],[10]
Par Amount / Unit		$ 10,000	[5]	$ 10,000	[8]
Cost		9,875	[5]	9,848	[8]
Fair Value		$ 9,123	[5]	$ 9,333	[8]
% of Net Assets		3.02%	[1],[5]	3.59%	[2],[8]
Investment, Identifier [Axis]: Chroma Color Corporation (dba "Chroma Color)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.75%
Interest Rate	[4],[5],[6]	11.15%
Par Amount / Unit	[4],[5]	$ 1,749
Cost	[4],[5]	1,715
Fair Value	[4],[5]	$ 1,716
% of Net Assets	[1],[4],[5]	0.57%
Investment, Identifier [Axis]: Chroma Color Corporation (dba "Chroma Color) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	5.75%
Interest Rate	[4],[5],[6],[12]	11.15%
Par Amount / Unit	[4],[5],[12]	$ 381
Cost	[4],[5],[12]	(4)
Fair Value	[4],[5],[12]	$ (7)
% of Net Assets	[1],[4],[5],[12]	0%
Investment, Identifier [Axis]: Cinemark USA Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.75%
Interest Rate	[4],[6],[18],[19]	9.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 499
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Clarios Global LP (f/k/a Johnson Controls Inc)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.75%
Interest Rate	[4],[6],[18],[19],[21]	9.15%
Par Amount / Unit	[4],[18],[19],[21]	$ 500
Cost	[4],[18],[19],[21]	502
Fair Value	[4],[18],[19],[21]	$ 500
% of Net Assets	[1],[4],[18],[19],[21]	0.17%
Investment, Identifier [Axis]: Class Valuation
Schedule of Investments [Line Items]
Interest Rate		11%	[5],[6]	11%	[8],[10]
Par Amount / Unit		$ 444	[5]	$ 444	[8]
Cost		437	[5]	436	[8]
Fair Value		$ 405	[5]	$ 415	[8]
% of Net Assets		0.13%	[1],[5]	0.16%	[2],[8]
Investment, Identifier [Axis]: Class Valuation 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 105
Fair Value	[5],[16],[17]	$ 28
% of Net Assets	[1],[5],[16],[17]	0.01%
Share / Unit	[5],[16],[17]	1,038
Investment, Identifier [Axis]: Cold Spring Brewing Company
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[4],[5],[6]	4.75%	[7],[8],[10]
Interest Rate		10.07%	[4],[5],[6]	9.11%	[7],[8],[10]
Par Amount / Unit		$ 6,288	[4],[5]	$ 6,805	[7],[8]
Cost		6,287	[4],[5]	6,805	[7],[8]
Fair Value		$ 6,287	[4],[5]	$ 6,804	[7],[8]
% of Net Assets		2.08%	[1],[4],[5]	2.61%	[2],[7],[8]
Investment, Identifier [Axis]: Copeland (Emerson Climate Technologies)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	3%
Interest Rate	[4],[6],[18]	8.32%
Par Amount / Unit	[4],[18]	$ 750
Cost	[4],[18]	753
Fair Value	[4],[18]	$ 750
% of Net Assets	[1],[4],[18]	0.25%
Investment, Identifier [Axis]: Covanta Holding Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 35
Cost	[4],[18],[19]	35
Fair Value	[4],[18],[19]	$ 35
% of Net Assets	[1],[4],[18],[19]	0.01%
Investment, Identifier [Axis]: Covanta Holding Corp 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 464
Cost	[4],[18],[19]	464
Fair Value	[4],[18],[19]	$ 462
% of Net Assets	[1],[4],[18],[19]	0.15%
Investment, Identifier [Axis]: CrossCountry Consulting
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11]	5.75%	[7],[8],[9],[10]
Interest Rate		11.07%	[4],[5],[6],[11]	10.34%	[7],[8],[9],[10]
Par Amount / Unit		$ 1,383	[4],[5],[11]	$ 1,393	[7],[8],[9]
Cost		1,359	[4],[5],[11]	1,367	[7],[8],[9]
Fair Value		$ 1,383	[4],[5],[11]	$ 1,376	[7],[8],[9]
% of Net Assets		0.45%	[1],[4],[5],[11]	0.53%	[2],[7],[8],[9]
Investment, Identifier [Axis]: CrossCountry Consulting (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[12]	5.75%	[8],[9],[10],[13]
Interest Rate		11.07%	[5],[6],[11],[12]	10.34%	[8],[9],[10],[13]
Par Amount / Unit		$ 560	[5],[11],[12]	$ 560	[8],[9],[13]
Cost		(5)	[5],[11],[12]	(5)	[8],[9],[13]
Fair Value		$ 0	[5],[11],[12]	$ (7)	[8],[9],[13]
% of Net Assets		0%	[1],[5],[11],[12]	0%	[2],[8],[9],[13]
Investment, Identifier [Axis]: DIRECTV (AKA DIRECTV Financing LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	5%
Interest Rate	[4],[6],[18],[19]	10.40%
Par Amount / Unit	[4],[18],[19]	$ 389
Cost	[4],[18],[19]	386
Fair Value	[4],[18],[19]	$ 381
% of Net Assets	[1],[4],[18],[19]	0.13%
Investment, Identifier [Axis]: Delta 2 (Lux) (Formula One) T/L B (09/23)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.25%
Interest Rate	[4],[6],[18],[19],[21]	8.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 750
Cost	[4],[18],[19],[21]	750
Fair Value	[4],[18],[19],[21]	$ 751
% of Net Assets	[1],[4],[18],[19],[21]	0.25%
Investment, Identifier [Axis]: Dresser Utility Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	4.25%	[7],[8],[10]
Interest Rate		10.57%	[4],[5],[6]	8.64%	[7],[8],[10]
Par Amount / Unit		$ 3,447	[4],[5]	$ 3,473	[7],[8]
Cost		3,447	[4],[5]	3,473	[7],[8]
Fair Value		$ 3,447	[4],[5]	$ 3,473	[7],[8]
% of Net Assets		1.14%	[1],[4],[5]	1.33%	[2],[7],[8]
Investment, Identifier [Axis]: Dresser Utility Solutions, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.57%	[4],[5],[6]	9.64%	[7],[8],[10]
Par Amount / Unit		$ 3,446	[4],[5]	$ 3,473	[7],[8]
Cost		3,413	[4],[5]	3,429	[7],[8]
Fair Value		$ 3,409	[4],[5]	$ 3,399	[7],[8]
% of Net Assets		1.13%	[1],[4],[5]	1.30%	[2],[7],[8]
Investment, Identifier [Axis]: EFC Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	11%
Interest Rate, PIK	[5],[6]	2.50%
Par Amount / Unit	[5],[12]	$ 2,420
Cost	[5],[12]	2,354
Fair Value	[5],[12]	$ 2,375
% of Net Assets	[1],[5],[12]	0.79%
Investment, Identifier [Axis]: EFC Holdings, LLC 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 114
Fair Value	[5],[16],[17],[19]	$ 119
% of Net Assets	[1],[5],[16],[17],[19]	0.04%
Share / Unit	[5],[16],[17],[19]	114
Investment, Identifier [Axis]: EFC Holdings, LLC 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 46
Fair Value	[5],[16],[17],[19]	$ 62
% of Net Assets	[1],[5],[16],[17],[19]	0.02%
Share / Unit	[5],[16],[17],[19]	114
Investment, Identifier [Axis]: Elevation Labs
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		11.15%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 1,305	[4],[5]	$ 1,315	[7],[8]
Cost		1,294	[4],[5]	1,303	[7],[8]
Fair Value		$ 1,260	[4],[5]	$ 1,301	[7],[8]
% of Net Assets		0.42%	[1],[4],[5]	0.50%	[2],[7],[8]
Investment, Identifier [Axis]: Elevation Labs (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[12]	5.25%	[7],[8],[10],[13]
Interest Rate		11.15%	[4],[5],[6],[12]	9.84%	[7],[8],[10],[13]
Par Amount / Unit		$ 599	[4],[5],[12]	$ 599	[7],[8],[13]
Cost		(2)	[4],[5],[12]	(3)	[7],[8],[13]
Fair Value		$ (21)	[4],[5],[12]	$ (6)	[7],[8],[13]
% of Net Assets		(0.01%)	[1],[4],[5],[12]	0%	[2],[7],[8],[13]
Investment, Identifier [Axis]: Evergreen Services Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[11]	6%	[7],[8],[9],[10]
Interest Rate		11.65%	[4],[5],[6],[11]	10.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 4,037	[4],[5],[11]	$ 4,068	[7],[8],[9]
Cost		3,967	[4],[5],[11]	3,991	[7],[8],[9]
Fair Value		$ 3,921	[4],[5],[11]	$ 3,971	[7],[8],[9]
% of Net Assets		1.30%	[1],[4],[5],[11]	1.52%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Evergreen Services Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[11]	6%	[7],[8],[9],[10],[13]
Interest Rate		11.65%	[4],[5],[6],[11]	10.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 966	[4],[5],[11]	$ 970	[7],[8],[9]
Cost		957	[4],[5],[11]	694	[7],[8],[9]
Fair Value		$ 938	[4],[5],[11]	$ 680	[7],[8],[9]
% of Net Assets		0.31%	[1],[4],[5],[11]	0.26%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Excel Fitness
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 5,940	[4],[5]	$ 5,985	[7],[8]
Cost		5,880	[4],[5]	5,920	[7],[8]
Fair Value		$ 5,735	[4],[5]	$ 5,690	[7],[8]
% of Net Assets		1.90%	[1],[4],[5]	2.19%	[2],[7],[8]
Investment, Identifier [Axis]: FCP-Cranium Holdings P/S A
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19],[21]	$ 0
Fair Value	[5],[16],[17],[19],[21]	$ 0
% of Net Assets	[1],[5],[16],[17],[19],[21]	0%
Share / Unit	[5],[16],[17],[19],[21]	375
Investment, Identifier [Axis]: FCP-Cranium Holdings, LLC (Brain labs)
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19],[21]	$ 389
Fair Value	[5],[16],[17],[19],[21]	$ 400
% of Net Assets	[1],[5],[16],[17],[19],[21]	0.13%
Share / Unit	[5],[16],[17],[19],[21]	1,026
Investment, Identifier [Axis]: FCP-Cranium Holdings, LLC (Brain labs) 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19],[21]	$ 600
Fair Value	[5],[16],[17],[19],[21]	$ 600
% of Net Assets	[1],[5],[16],[17],[19],[21]	0.20%
Share / Unit	[5],[16],[17],[19],[21]	375
Investment, Identifier [Axis]: FSK Pallet Holding Corp. (DBA Kamps Pallets)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5%	[7],[8],[10]
Interest Rate		10.90%	[4],[5],[6]	9.77%	[7],[8],[10]
Par Amount / Unit		$ 5,940	[4],[5]	$ 5,985	[7],[8]
Cost		5,843	[4],[5]	5,870	[7],[8]
Fair Value		$ 5,774	[4],[5]	$ 5,869	[7],[8]
% of Net Assets		1.91%	[1],[4],[5]	2.25%	[2],[7],[8]
Investment, Identifier [Axis]: Fortune International, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[4],[5],[6]	4.75%	[7],[8],[10]
Interest Rate		10.15%	[4],[5],[6]	9.52%	[7],[8],[10]
Par Amount / Unit		$ 6,896	[4],[5]	$ 6,948	[7],[8]
Cost		6,853	[4],[5]	6,891	[7],[8]
Fair Value		$ 6,805	[4],[5]	$ 6,802	[7],[8]
% of Net Assets		2.25%	[1],[4],[5]	2.61%	[2],[7],[8]
Investment, Identifier [Axis]: Freedom U.S. Acquisition Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[4],[5],[6]	4.50%	[7],[8],[10]
Interest Rate		9.90%	[4],[5],[6]	9.27%	[7],[8],[10]
Par Amount / Unit		$ 7,000	[4],[5]	$ 7,000	[7],[8]
Cost		7,000	[4],[5]	7,000	[7],[8]
Fair Value		$ 6,974	[4],[5]	$ 6,955	[7],[8]
% of Net Assets		2.31%	[1],[4],[5]	2.67%	[2],[7],[8]
Investment, Identifier [Axis]: Fresh Edge
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[4],[5],[6]	9%	[8],[10]
Interest Rate		15.09%	[4],[5],[6]	13.36%	[8],[10]
Interest Rate, PIK	[4],[5],[6]	5.125%
Par Amount / Unit		$ 2,916	[4],[5]	$ 2,890	[8]
Cost		2,848	[4],[5]	2,820	[8]
Fair Value		$ 2,833	[4],[5]	$ 2,820	[8]
% of Net Assets		0.94%	[1],[4],[5]	1.08%	[2],[8]
Investment, Identifier [Axis]: Fresh Edge - Common
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 0
Fair Value	[5],[16],[17]	$ 0
% of Net Assets	[1],[5],[16],[17]	0%
Share / Unit	[5],[16],[17]	454
Investment, Identifier [Axis]: Fresh Edge - Preferred
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 454
Fair Value	[5],[16],[17]	$ 413
% of Net Assets	[1],[5],[16],[17]	0.14%
Share / Unit	[5],[16],[17]	454
Investment, Identifier [Axis]: Fresh Edge 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost	[8],[14],[15]			$ 454
Fair Value	[8],[14],[15]			$ 454
% of Net Assets	[2],[8],[14],[15]			0.17%
Share / Unit	[8],[14],[15]			0
Investment, Identifier [Axis]: Fresh Edge 2
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost	[8],[14],[15]			$ 0
Fair Value	[8],[14],[15]			$ 0
% of Net Assets	[2],[8],[14],[15]			0%
Share / Unit	[8],[14],[15]			0
Investment, Identifier [Axis]: GFL Environmental T/L (1/23)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: GTCR W Merger Sub LLC (Worldpay)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 340
Cost	[4],[18],[19]	338
Fair Value	[4],[18],[19]	$ 340
% of Net Assets	[1],[4],[18],[19]	0.11%
Investment, Identifier [Axis]: Gannett Fleming
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.60%	[4],[5],[6]	6.50%	[7],[8],[10]
Interest Rate		12%	[4],[5],[6]	11.09%	[7],[8],[10]
Par Amount / Unit		$ 1,985	[4],[5]	$ 2,000	[7],[8]
Cost		1,949	[4],[5]	1,960	[7],[8]
Fair Value		$ 1,970	[4],[5]	$ 1,960	[7],[8]
% of Net Assets		0.65%	[1],[4],[5]	0.76%	[2],[7],[8]
Investment, Identifier [Axis]: Gannett Fleming 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 85	[5],[16],[17],[20]	$ 85	[8],[14],[15]
Fair Value		$ 99	[5],[16],[17],[20]	$ 85	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17],[20]	0.03%	[2],[8],[14],[15]
Share / Unit		84,949	[5],[16],[17],[20]	85	[8],[14],[15]
Investment, Identifier [Axis]: Gannett Fleming 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 118
Fair Value	[5],[16],[17]	$ 133
% of Net Assets	[1],[5],[16],[17]	0.04%
Share / Unit	[5],[16],[17]	113,901
Investment, Identifier [Axis]: GenServe LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11]	5.25%	[7],[8],[9],[10]
Interest Rate		11.22%	[4],[5],[6],[11]	9.84%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,895	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,873	[4],[5],[11]	6,891	[7],[8],[9]
Fair Value		$ 6,800	[4],[5],[11]	$ 6,937	[7],[8],[9]
% of Net Assets		2.25%	[1],[4],[5],[11]	2.66%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Getty Images Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	4.50%
Interest Rate	[4],[6],[18]	9.90%
Par Amount / Unit	[4],[18]	$ 498
Cost	[4],[18]	500
Fair Value	[4],[18]	$ 500
% of Net Assets	[1],[4],[18]	0.17%
Investment, Identifier [Axis]: Gray Television, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	498
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Grifols Worldwide Operations LTD
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2%
Interest Rate	[4],[6],[18],[19],[21]	7.40%
Par Amount / Unit	[4],[18],[19],[21]	$ 500
Cost	[4],[18],[19],[21]	496
Fair Value	[4],[18],[19],[21]	$ 492
% of Net Assets	[1],[4],[18],[19],[21]	0.16%
Investment, Identifier [Axis]: Harvest Hill Beverage Company
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	9%
Interest Rate	[5],[6]	14.32%
Par Amount / Unit	[5]	$ 2,800
Cost	[5]	2,721
Fair Value	[5]	$ 2,748
% of Net Assets	[1],[5]	0.91%
Investment, Identifier [Axis]: Hayward Industries, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	495
Fair Value	[4],[18],[19]	$ 496
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Health Management Associates
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 3,430
Cost	[4],[5]	3,365
Fair Value	[4],[5]	$ 3,399
% of Net Assets	[1],[4],[5]	1.12%
Investment, Identifier [Axis]: Health Management Associates (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 611
Cost	[4],[5],[12]	183
Fair Value	[4],[5],[12]	$ 190
% of Net Assets	[1],[4],[5],[12]	0.06%
Investment, Identifier [Axis]: Health Management Associates 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 162
Fair Value	[5],[16],[17]	$ 179
% of Net Assets	[1],[5],[16],[17]	0.06%
Share / Unit	[5],[16],[17]	161,953
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[5],[6]	7.50%	[8],[10]
Interest Rate		12.82%	[5],[6]	12.09%	[8],[10]
Par Amount / Unit		$ 1,000	[5]	$ 1,000	[8]
Cost		984	[5]	982	[8]
Fair Value		$ 978	[5]	$ 980	[8]
% of Net Assets		0.33%	[1],[5]	0.38%	[2],[8]
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[5],[6],[12]	7.50%	[8],[10],[13]
Interest Rate		12.82%	[5],[6],[12]	12.09%	[8],[10],[13]
Par Amount / Unit		$ 5,000	[5],[12]	$ 5,000	[8],[13]
Cost		2,790	[5],[12]	0	[8],[13]
Fair Value		$ 2,680	[5],[12]	$ (100)	[8],[13]
% of Net Assets		0.89%	[1],[5],[12]	(0.04%)	[2],[8],[13]
Investment, Identifier [Axis]: Hyphen Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	9.89%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,895	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,855	[4],[5],[11]	6,898	[7],[8],[9]
Fair Value		$ 6,688	[4],[5],[11]	$ 6,804	[7],[8],[9]
% of Net Assets		2.21%	[1],[4],[5],[11]	2.61%	[2],[7],[8],[9]
Investment, Identifier [Axis]: ICON Publishing Ltd
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 92
Cost	[4],[18],[19]	92
Fair Value	[4],[18],[19]	$ 92
% of Net Assets	[1],[4],[18],[19]	0.03%
Investment, Identifier [Axis]: ICON Publishing Ltd 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.25%
Interest Rate	[4],[6],[18],[19],[21]	7.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 369
Cost	[4],[18],[19],[21]	370
Fair Value	[4],[18],[19],[21]	$ 369
% of Net Assets	[1],[4],[18],[19],[21]	0.12%
Investment, Identifier [Axis]: II-VI Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: INEOS US Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.75%
Interest Rate	[4],[6],[18],[19]	9.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 497
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: INEOS US Petrochem LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 4,595
Cost	[4],[5]	4,513
Fair Value	[4],[5]	$ 4,557
% of Net Assets	[1],[4],[5]	1.51%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 1,139
Cost	[4],[5],[12]	(20)
Fair Value	[4],[5],[12]	$ (9)
% of Net Assets	[1],[4],[5],[12]	0%
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	6.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	10.61%	[7],[8],[10]
Par Amount / Unit		$ 2,460	[4],[5]	$ 2,479	[7],[8]
Cost		2,415	[4],[5]	2,429	[7],[8]
Fair Value		$ 2,440	[4],[5]	$ 2,429	[7],[8]
% of Net Assets		0.81%	[1],[4],[5]	0.93%	[2],[7],[8]
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[12]	6.25%	[7],[8],[10],[13]
Interest Rate		11.65%	[4],[5],[6],[12]	10.61%	[7],[8],[10],[13]
Par Amount / Unit		$ 1,281	[4],[5],[12]	$ 1,282	[7],[8],[13]
Cost		509	[4],[5],[12]	(6)	[7],[8],[13]
Fair Value		$ 505	[4],[5],[12]	$ (25)	[7],[8],[13]
% of Net Assets		0.17%	[1],[4],[5],[12]	(0.01%)	[2],[7],[8],[13]
Investment, Identifier [Axis]: ITSavvy LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.97%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 1,780	[4],[5]	$ 1,793	[7],[8]
Cost		1,765	[4],[5]	1,776	[7],[8]
Fair Value		$ 1,780	[4],[5]	$ 1,793	[7],[8]
% of Net Assets		0.59%	[1],[4],[5]	0.69%	[2],[7],[8]
Investment, Identifier [Axis]: ITSavvy LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12]	5.25%	[8],[10],[13]
Interest Rate		10.90%	[5],[6],[12]	9.84%	[8],[10],[13]
Par Amount / Unit		$ 335	[5],[12]	$ 480	[8],[13]
Cost		296	[5],[12]	(5)	[8],[13]
Fair Value		$ 299	[5],[12]	$ 0	[8],[13]
% of Net Assets		0.10%	[1],[5],[12]	0%	[2],[8],[13]
Investment, Identifier [Axis]: ITSavvy LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 119	[5],[16],[17]	$ 119	[8],[14],[15]
Fair Value		$ 237	[5],[16],[17]	$ 158	[8],[14],[15]
% of Net Assets		0.08%	[1],[5],[16],[17]	0.06%	[2],[8],[14],[15]
Share / Unit		119	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: Image International Intermediate Holdco II, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	10.27%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,992	[4],[5],[11]	$ 6,992	[7],[8],[9]
Cost		6,958	[4],[5],[11]	6,950	[7],[8],[9]
Fair Value		$ 6,868	[4],[5],[11]	$ 6,873	[7],[8],[9]
% of Net Assets		2.27%	[1],[4],[5],[11]	2.64%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6%
Interest Rate	[4],[5],[6]	11.47%
Par Amount / Unit	[4],[5]	$ 2,081
Cost	[4],[5]	2,040
Fair Value	[4],[5]	$ 2,043
% of Net Assets	[1],[4],[5]	0.68%
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6%
Interest Rate	[4],[5],[6],[12]	11.47%
Par Amount / Unit	[4],[5],[12]	$ 972
Cost	[4],[5],[12]	851
Fair Value	[4],[5],[12]	$ 838
% of Net Assets	[1],[4],[5],[12]	0.28%
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6%
Interest Rate	[4],[5],[6]	11.47%
Par Amount / Unit	[4],[5]	$ 427
Cost	[4],[5]	418
Fair Value	[4],[5]	$ 419
% of Net Assets	[1],[4],[5]	0.13%
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group) (Second Amendment Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6%
Interest Rate	[4],[5],[6],[12]	11.47%
Par Amount / Unit	[4],[5],[12]	$ 1,716
Cost	[4],[5],[12]	(8)
Fair Value	[4],[5],[12]	$ (31)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Infinite Bidco LLC (Infinite Electronics) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11]	6.25%
Interest Rate	[4],[5],[6],[11]	11.72%
Par Amount / Unit	[4],[5],[11]	$ 1,972
Cost	[4],[5],[11]	1,919
Fair Value	[4],[5],[11]	$ 1,920
% of Net Assets	[1],[4],[5],[11]	0.64%
Investment, Identifier [Axis]: Infobase Acquisition, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.50%	[7],[8],[10]
Interest Rate		10.97%	[4],[5],[6]	10.09%	[7],[8],[10]
Par Amount / Unit		$ 733	[4],[5]	$ 738	[7],[8]
Cost		727	[4],[5]	731	[7],[8]
Fair Value		$ 725	[4],[5]	$ 729	[7],[8]
% of Net Assets		0.24%	[1],[4],[5]	0.28%	[2],[7],[8]
Investment, Identifier [Axis]: Infobase Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12]	5.50%	[8],[10],[13]
Interest Rate		10.97%	[5],[6],[12]	10.09%	[8],[10],[13]
Par Amount / Unit		$ 122	[5],[12]	$ 122	[8],[13]
Cost		0	[5],[12]	0	[8],[13]
Fair Value		$ (1)	[5],[12]	$ (2)	[8],[13]
% of Net Assets		0%	[1],[5],[12]	0%	[2],[8],[13]
Investment, Identifier [Axis]: Informatica LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	752
Fair Value	[4],[18],[19]	$ 747
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Ingram Micro T/L (09/23) TARGET FACILITY
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Instructure Holdings Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Intelsat Jackson Holdings S.A.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	4.25%
Interest Rate	[4],[6],[18],[19],[21]	9.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 488
Cost	[4],[18],[19],[21]	489
Fair Value	[4],[18],[19],[21]	$ 488
% of Net Assets	[1],[4],[18],[19],[21]	0.16%
Investment, Identifier [Axis]: Iridium Satellite LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Jazz Pharmaceuticals plc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.50%
Interest Rate	[4],[6],[18],[19],[21]	8.90%
Par Amount / Unit	[4],[18],[19],[21]	$ 748
Cost	[4],[18],[19],[21]	750
Fair Value	[4],[18],[19],[21]	$ 748
% of Net Assets	[1],[4],[18],[19],[21]	0.25%
Investment, Identifier [Axis]: KRIV Acquisition, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 5,221
Cost	[4],[5]	5,078
Fair Value	[4],[5]	$ 5,068
% of Net Assets	[1],[4],[5]	1.68%
Investment, Identifier [Axis]: KRIV Acquisition, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 779
Cost	[4],[5],[12]	(10)
Fair Value	[4],[5],[12]	$ (23)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: KRIV Acquisition, Inc 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 200
Fair Value	[5],[16],[17]	$ 200
% of Net Assets	[1],[5],[16],[17]	0.07%
Share / Unit	[5],[16],[17]	200
Investment, Identifier [Axis]: Kenco Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6]	5.50%	[7],[8],[10]
Interest Rate		10.40%	[4],[5],[6]	10.09%	[7],[8],[10]
Par Amount / Unit		$ 5,112	[4],[5]	$ 5,150	[7],[8]
Cost		5,020	[4],[5]	5,049	[7],[8]
Fair Value		$ 5,099	[4],[5]	$ 5,049	[7],[8]
% of Net Assets		1.69%	[1],[4],[5]	1.94%	[2],[7],[8]
Investment, Identifier [Axis]: Kenco Group, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6],[12]	5.50%	[7],[8],[10],[13]
Interest Rate		10.40%	[4],[5],[6],[12]	10.09%	[7],[8],[10],[13]
Par Amount / Unit		$ 850	[4],[5],[12]	$ 850	[7],[8],[13]
Cost		(15)	[4],[5],[12]	(17)	[7],[8],[13]
Fair Value		$ (2)	[4],[5],[12]	$ (17)	[7],[8],[13]
% of Net Assets		0%	[1],[4],[5],[12]	(0.01%)	[2],[7],[8],[13]
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11]	6.25%
Interest Rate	[4],[5],[6],[11]	11.65%
Par Amount / Unit	[4],[5],[11]	$ 2,431
Cost	[4],[5],[11]	2,395
Fair Value	[4],[5],[11]	$ 2,396
% of Net Assets	[1],[4],[5],[11]	0.79%
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11],[12]	6.25%
Interest Rate	[4],[5],[6],[11],[12]	11.65%
Par Amount / Unit	[4],[5],[11],[12]	$ 2,342
Cost	[4],[5],[11],[12]	296
Fair Value	[4],[5],[11],[12]	$ 269
% of Net Assets	[1],[4],[5],[11],[12]	0.09%
Investment, Identifier [Axis]: Kofile, Inc.
Schedule of Investments [Line Items]
Interest Rate		10%	[5],[6]	10%	[8],[10]
Interest Rate, PIK		1.75%	[5],[6]	1.75%	[8],[10]
Par Amount / Unit		$ 10,263	[5]	$ 10,128	[8]
Cost		10,263	[5]	10,128	[8]
Fair Value		$ 9,629	[5]	$ 9,987	[8]
% of Net Assets		3.19%	[1],[5]	3.84%	[2],[8]
Investment, Identifier [Axis]: Kofile, Inc. 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost	[8],[14],[15]			$ 108
Fair Value	[8],[14],[15]			$ 78
% of Net Assets	[2],[8],[14],[15]			0.03%
Share / Unit	[8],[14],[15]			0
Investment, Identifier [Axis]: Kofile, Inc. 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 108
Fair Value	[5],[16],[17]	$ 61
% of Net Assets	[1],[5],[16],[17]	0.02%
Share / Unit	[5],[16],[17]	100
Investment, Identifier [Axis]: Kraton Polymers LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.25%
Interest Rate	[4],[6],[18],[19]	8.65%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	493
Fair Value	[4],[18],[19]	$ 494
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6]	6.50%	[7],[8],[10]
Interest Rate		11.90%	[4],[5],[6]	11.09%	[7],[8],[10]
Par Amount / Unit		$ 736	[4],[5]	$ 742	[7],[8]
Cost		724	[4],[5]	728	[7],[8]
Fair Value		$ 731	[4],[5]	$ 718	[7],[8]
% of Net Assets		0.24%	[1],[4],[5]	0.28%	[2],[7],[8]
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6]	6.50%	[7],[8],[10]
Interest Rate		11.90%	[4],[5],[6]	11.09%	[7],[8],[10]
Par Amount / Unit		$ 2,963	[4],[5]	$ 2,985	[7],[8]
Cost		2,878	[4],[5]	2,889	[7],[8]
Fair Value		$ 2,940	[4],[5]	$ 2,889	[7],[8]
% of Net Assets		0.98%	[1],[4],[5]	1.11%	[2],[7],[8]
Investment, Identifier [Axis]: LMI Renaissance
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 107	[5],[16],[17]	$ 107	[8],[14],[15]
Fair Value		$ 217	[5],[16],[17]	$ 180	[8],[14],[15]
% of Net Assets		0.07%	[1],[5],[16],[17]	0.07%	[2],[8],[14],[15]
Share / Unit		106,984	[5],[16],[17]	107	[8],[14],[15]
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 4,075
Cost	[4],[5]	4,001
Fair Value	[4],[5]	$ 4,001
% of Net Assets	[1],[4],[5]	1.32%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 1,898
Cost	[4],[5],[12]	1,410
Fair Value	[4],[5],[12]	$ 1,384
% of Net Assets	[1],[4],[5],[12]	0.46%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 196
Fair Value	[5],[16],[17]	$ 203
% of Net Assets	[1],[5],[16],[17]	0.07%
Share / Unit	[5],[16],[17]	1,963
Investment, Identifier [Axis]: MEI Rigging & Crating
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.82%
Par Amount / Unit	[4],[5]	$ 3,166
Cost	[4],[5]	3,103
Fair Value	[4],[5]	$ 3,105
% of Net Assets	[1],[4],[5]	1.03%
Investment, Identifier [Axis]: MEI Rigging & Crating (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.82%
Par Amount / Unit	[4],[5],[12]	$ 501
Cost	[4],[5],[12]	(2)
Fair Value	[4],[5],[12]	$ (10)
% of Net Assets	[1],[4],[5],[12]	0%
Investment, Identifier [Axis]: MKS Instruments Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 499
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Marco APE Opco Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10]			10.50%
Interest Rate, PIK	[8],[10]	15%		4.25%
Par Amount / Unit		$ 9,523	[5]	$ 8,633	[8]
Cost		9,071	[5]	8,103	[8]
Fair Value		$ 8,306	[5]	$ 7,458	[8]
% of Net Assets		2.75%	[1],[5]	2.87%	[2],[8]
Investment, Identifier [Axis]: Marlin Coinvest LP
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 200
Fair Value	[5],[16],[17]	$ 456
% of Net Assets	[1],[5],[16],[17]	0.15%
Share / Unit	[5],[16],[17]	200,000
Investment, Identifier [Axis]: Messer Industries GmbH
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 498
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Mr. Greens
Schedule of Investments [Line Items]
Interest Rate	[8],[10]			10%
Interest Rate, PIK	[8],[10]			2%
Par Amount / Unit	[8]			$ 10,153
Cost	[8]			9,807
Fair Value	[8]			$ 10,153
% of Net Assets	[2],[8]			3.90%
Investment, Identifier [Axis]: Mr. Greens 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost	[8],[14],[15]			$ 101
Fair Value	[8],[14],[15]			$ 276
% of Net Assets	[2],[8],[14],[15]			0.11%
Share / Unit	[8],[14],[15]			1
Investment, Identifier [Axis]: NCR Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: NMC Skincare Intermediate Holdings II, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6],[11]	5%	[7],[8],[9],[10]
Interest Rate		10.32%	[4],[5],[6],[11]	9.77%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,892	[4],[5],[11]	$ 6,946	[7],[8],[9]
Cost		6,834	[4],[5],[11]	6,849	[7],[8],[9]
Fair Value		$ 6,606	[4],[5],[11]	$ 6,672	[7],[8],[9]
% of Net Assets		2.19%	[1],[4],[5],[11]	2.56%	[2],[7],[8],[9]
Investment, Identifier [Axis]: New Era Technology, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[11]	6.25%	[7],[8],[9],[10]
Interest Rate		11.65%	[4],[5],[6],[11]	11.02%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,741	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,720	[4],[5],[11]	6,919	[7],[8],[9]
Fair Value		$ 6,553	[4],[5],[11]	$ 6,650	[7],[8],[9]
% of Net Assets		2.17%	[1],[4],[5],[11]	2.56%	[2],[7],[8],[9]
Investment, Identifier [Axis]: New ILC Dover, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6],[11]	5%	[7],[8],[9],[10]
Interest Rate		10.40%	[4],[5],[6],[11]	9.77%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,893	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,885	[4],[5],[11]	6,935	[7],[8],[9]
Fair Value		$ 6,893	[4],[5],[11]	$ 6,946	[7],[8],[9]
% of Net Assets		2.28%	[1],[4],[5],[11]	2.67%	[2],[7],[8],[9]
Investment, Identifier [Axis]: New You Bariatric Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 6,892	[4],[5]	$ 6,946	[7],[8]
Cost		6,892	[4],[5]	6,946	[7],[8]
Fair Value		$ 6,641	[4],[5]	$ 6,838	[7],[8]
% of Net Assets		2.20%	[1],[4],[5]	2.63%	[2],[7],[8]
Investment, Identifier [Axis]: Nexstar Media Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Nonni's Foods, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5%	[7],[8],[10]
Interest Rate		10.97%	[4],[5],[6]	9.39%	[7],[8],[10]
Par Amount / Unit		$ 6,909	[4],[5]	$ 6,963	[7],[8]
Cost		6,908	[4],[5]	6,958	[7],[8]
Fair Value		$ 6,838	[4],[5]	$ 6,915	[7],[8]
% of Net Assets		2.26%	[1],[4],[5]	2.66%	[2],[7],[8]
Investment, Identifier [Axis]: North Haven Stack Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	9.86%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,894	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,871	[4],[5],[11]	6,918	[7],[8],[9]
Fair Value		$ 6,793	[4],[5],[11]	$ 6,845	[7],[8],[9]
% of Net Assets		2.25%	[1],[4],[5],[11]	2.63%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Norton Lifelock Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2%
Interest Rate	[4],[6],[18],[19]	7.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Nouryon Finance B.V.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	4%
Interest Rate	[4],[6],[18],[19]	9.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 494
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Nutrition 101 Buyer LLC (a/k/a 101, Inc.)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.65%	[4],[5],[6]	9.61%	[7],[8],[10]
Par Amount / Unit		$ 818	[4],[5]	$ 824	[7],[8]
Cost		811	[4],[5]	816	[7],[8]
Fair Value		$ 806	[4],[5]	$ 816	[7],[8]
% of Net Assets		0.27%	[1],[4],[5]	0.31%	[2],[7],[8]
Investment, Identifier [Axis]: OMNIA Partners, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11]	4.25%
Interest Rate	[4],[5],[6],[11]	9.65%
Par Amount / Unit	[4],[5],[11]	$ 1,371
Cost	[4],[5],[11]	1,358
Fair Value	[4],[5],[11]	$ 1,358
% of Net Assets	[1],[4],[5],[11]	0.45%
Investment, Identifier [Axis]: OMNIA Partners, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11],[12]	4.25%
Interest Rate	[4],[5],[6],[11],[12]	9.65%
Par Amount / Unit	[4],[5],[11],[12]	$ 129
Cost	[4],[5],[11],[12]	(1)
Fair Value	[4],[5],[11],[12]	$ (1)
% of Net Assets	[1],[4],[5],[11],[12]	0%
Investment, Identifier [Axis]: Oliver Packaging
Schedule of Investments [Line Items]
Interest Rate		11%	[5],[6]	10%	[8],[10]
Interest Rate, PIK	[8],[10]			1%
Par Amount / Unit		$ 1,326	[5]	$ 1,332	[8]
Cost		1,304	[5]	1,308	[8]
Fair Value		$ 1,266	[5]	$ 1,265	[8]
% of Net Assets		0.42%	[1],[5]	0.48%	[2],[8]
Investment, Identifier [Axis]: Oliver Packaging 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 671	[5],[16],[17]	$ 610	[8],[14],[15]
Fair Value		$ 523	[5],[16],[17]	$ 639	[8],[14],[15]
% of Net Assets		0.17%	[1],[5],[16],[17]	0.25%	[2],[8],[14],[15]
Share / Unit		6,710	[5],[16],[17]	6	[8],[14],[15]
Investment, Identifier [Axis]: Open Text Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.75%
Interest Rate	[4],[6],[18],[19],[21]	8.15%
Par Amount / Unit	[4],[18],[19],[21]	$ 748
Cost	[4],[18],[19],[21]	750
Fair Value	[4],[18],[19],[21]	$ 749
% of Net Assets	[1],[4],[18],[19],[21]	0.25%
Investment, Identifier [Axis]: Organon & Co
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 750
Cost	[4],[18],[19]	754
Fair Value	[4],[18],[19]	$ 750
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.65%
Par Amount / Unit	[4],[5]	$ 3,429
Cost	[4],[5]	3,378
Fair Value	[4],[5]	$ 3,380
% of Net Assets	[1],[4],[5]	1.12%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.65%
Par Amount / Unit	[4],[5],[12]	$ 2,571
Cost	[4],[5],[12]	(6)
Fair Value	[4],[5],[12]	$ (36)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Ovation Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.65%
Par Amount / Unit	[4],[5]	$ 2,980
Cost	[4],[5]	2,920
Fair Value	[4],[5]	$ 2,934
% of Net Assets	[1],[4],[5]	0.97%
Investment, Identifier [Axis]: Ovation Holdings, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.65%
Par Amount / Unit	[4],[5],[12]	$ 704
Cost	[4],[5],[12]	226
Fair Value	[4],[5],[12]	$ 223
% of Net Assets	[1],[4],[5],[12]	0.07%
Investment, Identifier [Axis]: PG Aggregator, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 109	[5],[16],[17]	$ 109	[8],[14],[15]
Fair Value		$ 140	[5],[16],[17]	$ 135	[8],[14],[15]
% of Net Assets		0.05%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		100	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: PG Buyer, LLC
Schedule of Investments [Line Items]
Interest Rate		10%	[4],[5],[6]	10%
Interest Rate, PIK		1.50%	[4],[5],[6]	1.50%
Par Amount / Unit		$ 8,184	[4],[5]	$ 8,092	[8]
Cost		8,184	[4],[5]	8,092	[8]
Fair Value		$ 8,184	[4],[5]	$ 8,092	[8]
% of Net Assets		2.71%	[1],[4],[5]	3.11%	[2],[8]
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.75%
Interest Rate	[4],[5],[6]	11.15%
Par Amount / Unit	[4],[5]	$ 3,348
Cost	[4],[5]	3,290
Fair Value	[4],[5]	$ 3,290
% of Net Assets	[1],[4],[5]	1.09%
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	5.75%
Interest Rate	[4],[5],[6],[12]	11.15%
Par Amount / Unit	[4],[5],[12]	$ 1,217
Cost	[4],[5],[12]	(5)
Fair Value	[4],[5],[12]	$ (21)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Patriot Growth Insurance Service (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11],[12]	5.75%	[7],[8],[9],[10],[13]
Interest Rate		11.15%	[4],[5],[6],[11],[12]	10.52%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 5,980	[4],[5],[11],[12]	$ 5,999	[7],[8],[9],[13]
Cost		3,839	[4],[5],[11],[12]	375	[7],[8],[9],[13]
Fair Value		$ 3,726	[4],[5],[11],[12]	$ 266	[7],[8],[9],[13]
% of Net Assets		1.23%	[1],[4],[5],[11],[12]	0.10%	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: Perennial Services Investors LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 196
Fair Value	[5],[16],[17],[19]	$ 196
% of Net Assets	[1],[5],[16],[17],[19]	0.06%
Share / Unit	[5],[16],[17],[19]	1,957
Investment, Identifier [Axis]: Perennial Services, Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6%
Interest Rate	[4],[5],[6]	11.40%
Par Amount / Unit	[4],[5]	$ 1,697
Cost	[4],[5]	1,672
Fair Value	[4],[5]	$ 1,672
% of Net Assets	[1],[4],[5]	0.55%
Investment, Identifier [Axis]: Perennial Services, Group, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6%
Interest Rate	[4],[5],[6],[12]	11.40%
Par Amount / Unit	[4],[5],[12]	$ 1,516
Cost	[4],[5],[12]	193
Fair Value	[4],[5],[12]	$ 175
% of Net Assets	[1],[4],[5],[12]	0.05%
Investment, Identifier [Axis]: Perrigo Company plc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Phaidon International
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[19],[21]	5.50%	[7],[8],[10]
Interest Rate		10.82%	[4],[5],[6],[19],[21]	9.86%	[7],[8],[10],[22],[23]
Par Amount / Unit		$ 6,626	[4],[5],[19],[21]	$ 7,000	[7],[8],[22],[23]
Cost		6,568	[4],[5],[19],[21]	6,932	[7],[8],[22],[23]
Fair Value		$ 6,521	[4],[5],[19],[21]	$ 6,916	[7],[8],[22],[23]
% of Net Assets		2.16%	[1],[4],[5],[19],[21]	2.66%	[2],[7],[8],[22],[23]
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6%
Interest Rate	[4],[5],[6],[12]	11.40%
Par Amount / Unit	[4],[5],[12]	$ 1,455
Cost	[4],[5],[12]	(13)
Fair Value	[4],[5],[12]	$ (27)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6%
Interest Rate	[4],[5],[6]	11.40%
Par Amount / Unit	[4],[5]	$ 2,539
Cost	[4],[5]	2,490
Fair Value	[4],[5]	$ 2,492
% of Net Assets	[1],[4],[5]	0.83%
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 112
Fair Value	[5],[16],[17]	$ 103
% of Net Assets	[1],[5],[16],[17]	0.03%
Share / Unit	[5],[16],[17]	111,875
Investment, Identifier [Axis]: Prime Security Services Borrower LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	750
Fair Value	[4],[18],[19]	$ 748
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Protective Industrial Products (“PIP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5%
Interest Rate	[4],[5],[6]	10.32%
Par Amount / Unit	[4],[5]	$ 1,346
Cost	[4],[5]	1,295
Fair Value	[4],[5]	$ 1,346
% of Net Assets	[1],[4],[5]	0.45%
Investment, Identifier [Axis]: Quikrete Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	2.75%
Interest Rate	[4],[6],[18]	8.15%
Par Amount / Unit	[4],[18]	$ 499
Cost	[4],[18]	500
Fair Value	[4],[18]	$ 499
% of Net Assets	[1],[4],[18]	0.17%
Investment, Identifier [Axis]: RTH Buyer LLC (dba "Rhino Tool House)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.72%
Par Amount / Unit	[4],[5]	$ 2,680
Cost	[4],[5]	2,628
Fair Value	[4],[5]	$ 2,657
% of Net Assets	[1],[4],[5]	0.88%
Investment, Identifier [Axis]: RTH Buyer LLC (dba "Rhino Tool House) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.72%
Par Amount / Unit	[4],[5],[12]	$ 627
Cost	[4],[5],[12]	300
Fair Value	[4],[5],[12]	$ 298
% of Net Assets	[1],[4],[5],[12]	0.10%
Investment, Identifier [Axis]: RVGD Aggregator LP (Revision Skincare)
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 98	[5],[16],[17]	$ 98	[8],[14],[15]
Fair Value		$ 108	[5],[16],[17]	$ 133	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		100	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: Randys Holdings, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6],[11]	6.50%	[7],[8],[9],[10]
Interest Rate		11.90%	[4],[5],[6],[11]	11.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 3,967	[4],[5],[11]	$ 3,996	[7],[8],[9]
Cost		3,895	[4],[5],[11]	3,918	[7],[8],[9]
Fair Value		$ 3,915	[4],[5],[11]	$ 3,919	[7],[8],[9]
% of Net Assets		1.30%	[1],[4],[5],[11]	1.51%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Randys Holdings, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6],[11],[12]	6.50%	[7],[8],[9],[10],[13]
Interest Rate		11.90%	[4],[5],[6],[11],[12]	11.09%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 1,332	[4],[5],[11],[12]	$ 1,332	[7],[8],[9],[13]
Cost		0	[4],[5],[11],[12]	0	[7],[8],[9],[13]
Fair Value		$ (17)	[4],[5],[11],[12]	$ (26)	[7],[8],[9],[13]
% of Net Assets		(0.01%)	[1],[4],[5],[11],[12]	(0.01%)	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: Red Dawn SEI Buyer, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.25%	[5],[6]	8.25%	[8],[10]
Interest Rate		13.65%	[5],[6]	13.02%	[8],[10]
Par Amount / Unit		$ 6,650	[5]	$ 6,650	[8]
Cost		6,650	[5]	6,650	[8]
Fair Value		$ 6,601	[5]	$ 6,650	[8]
% of Net Assets		2.18%	[1],[5]	2.54%	[2],[8]
Investment, Identifier [Axis]: Red Dawn SEI Buyer, Inc. (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.50%	[5],[6]	8.50%	[8],[10]
Interest Rate		13.90%	[5],[6]	13.27%	[8],[10]
Par Amount / Unit		$ 3,350	[5]	$ 3,350	[8]
Cost		3,350	[5]	3,350	[8]
Fair Value		$ 3,347	[5]	$ 3,350	[8]
% of Net Assets		1.11%	[1],[5]	1.29%	[2],[8]
Investment, Identifier [Axis]: Red Ventures LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	3%
Interest Rate	[4],[6],[18]	8.40%
Par Amount / Unit	[4],[18]	$ 499
Cost	[4],[18]	499
Fair Value	[4],[18]	$ 496
% of Net Assets	[1],[4],[18]	0.16%
Investment, Identifier [Axis]: Revision Buyer LLC
Schedule of Investments [Line Items]
Interest Rate		10%	[5],[6]	10%	[8],[10]
Interest Rate, PIK		1%	[5],[6]	1%	[8],[10]
Par Amount / Unit		$ 10,151	[5]	$ 10,075	[8]
Cost		9,982	[5]	9,889	[8]
Fair Value		$ 10,151	[5]	$ 9,896	[8]
% of Net Assets		3.36%	[1],[5]	3.80%	[2],[8]
Investment, Identifier [Axis]: Ryan Specialty Group LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6]	5.75%	[7],[8],[10]
Interest Rate		11.07%	[4],[5],[6]	10.34%	[7],[8],[10]
Par Amount / Unit		$ 2,248	[4],[5]	$ 2,265	[7],[8]
Cost		2,204	[4],[5]	2,217	[7],[8]
Fair Value		$ 2,220	[4],[5]	$ 2,221	[7],[8]
% of Net Assets		0.73%	[1],[4],[5]	0.85%	[2],[7],[8]
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[12]	5.75%	[7],[8],[10],[13]
Interest Rate		11.07%	[4],[5],[6],[12]	10.34%	[7],[8],[10],[13]
Par Amount / Unit		$ 734	[4],[5],[12]	$ 735	[7],[8],[13]
Cost		348	[4],[5],[12]	0	[7],[8],[13]
Fair Value		$ 339	[4],[5],[12]	$ (14)	[7],[8],[13]
% of Net Assets		0.11%	[1],[4],[5],[12]	(0.01%)	[2],[7],[8],[13]
Investment, Identifier [Axis]: SPI LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6],[11]	5%	[7],[8],[9],[10]
Interest Rate		10.32%	[4],[5],[6],[11]	9.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,895	[4],[5],[11]	$ 6,948	[7],[8],[9]
Cost		6,814	[4],[5],[11]	6,855	[7],[8],[9]
Fair Value		$ 6,895	[4],[5],[11]	$ 6,804	[7],[8],[9]
% of Net Assets		2.28%	[1],[4],[5],[11]	2.61%	[2],[7],[8],[9]
Investment, Identifier [Axis]: SRAM LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	2.75%
Interest Rate	[4],[6],[18]	8.15%
Par Amount / Unit	[4],[18]	$ 500
Cost	[4],[18]	501
Fair Value	[4],[18]	$ 499
% of Net Assets	[1],[4],[18]	0.16%
Investment, Identifier [Axis]: SS&C Technology Holdings Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.25%
Interest Rate	[4],[6],[18],[19]	7.65%
Par Amount / Unit	[4],[18],[19]	$ 199
Cost	[4],[18],[19]	199
Fair Value	[4],[18],[19]	$ 199
% of Net Assets	[1],[4],[18],[19]	0.07%
Investment, Identifier [Axis]: SS&C Technology Holdings Inc 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.25%
Interest Rate	[4],[6],[18],[19]	7.65%
Par Amount / Unit	[4],[18],[19]	$ 300
Cost	[4],[18],[19]	301
Fair Value	[4],[18],[19]	$ 300
% of Net Assets	[1],[4],[18],[19]	0.10%
Investment, Identifier [Axis]: SW Ingredients Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate		10.50%	[5],[6]	10.50%	[8],[10]
Interest Rate, PIK		1%	[5],[6]	1%	[8],[10]
Par Amount / Unit		$ 10,153	[5]	$ 10,076	[8]
Cost		10,153	[5]	10,076	[8]
Fair Value		$ 9,902	[5]	$ 9,521	[8]
% of Net Assets		3.28%	[1],[5]	3.67%	[2],[8]
Investment, Identifier [Axis]: Select Medical Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	752
Fair Value	[4],[18],[19]	$ 747
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Solaray, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6],[11]	5.75%	[7],[8],[9],[10]
Interest Rate		11.90%	[4],[5],[6],[11]	10.34%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,907	[4],[5],[11]	$ 6,963	[7],[8],[9]
Cost		6,902	[4],[5],[11]	6,955	[7],[8],[9]
Fair Value		$ 6,731	[4],[5],[11]	$ 6,878	[7],[8],[9]
% of Net Assets		2.23%	[1],[4],[5],[11]	2.64%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Southern Veterinary Partners
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[9],[10]			5.50%
Interest Rate	[7],[8],[9],[10]			9.86%
Par Amount / Unit	[7],[8],[9]			$ 3,085
Cost	[7],[8],[9]			3,026
Fair Value	[7],[8],[9]			$ 3,022
% of Net Assets	[2],[7],[8],[9]			1.16%
Investment, Identifier [Axis]: Spartech
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[4],[5],[6],[11]	4.75%	[7],[8],[9],[10]
Interest Rate		10.15%	[4],[5],[6],[11]	9.52%	[7],[8],[9],[10]
Par Amount / Unit		$ 3,940	[4],[5],[11]	$ 3,970	[7],[8],[9]
Cost		3,940	[4],[5],[11]	3,970	[7],[8],[9]
Fair Value		$ 3,320	[4],[5],[11]	$ 3,863	[7],[8],[9]
% of Net Assets		1.10%	[1],[4],[5],[11]	1.48%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Specialist Resources Global Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6]	4.50%	[7],[8],[10]
Interest Rate		10.32%	[4],[5],[6]	8.89%	[7],[8],[10]
Par Amount / Unit		$ 6,894	[4],[5]	$ 6,947	[7],[8]
Cost		6,894	[4],[5]	6,947	[7],[8]
Fair Value		$ 6,894	[4],[5]	$ 6,894	[7],[8]
% of Net Assets		2.28%	[1],[4],[5]	2.65%	[2],[7],[8]
Investment, Identifier [Axis]: Spice World
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 126	[5],[16],[17],[19]	$ 126	[8],[14],[15]
Fair Value		$ 125	[5],[16],[17],[19]	$ 101	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17],[19]	0.04%	[2],[8],[14],[15]
Share / Unit		1,000	[5],[16],[17],[19]	1	[8],[14],[15]
Investment, Identifier [Axis]: Sugar PPC Holdings LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 200
Fair Value	[5],[16],[17],[19]	$ 200
% of Net Assets	[1],[5],[16],[17],[19]	0.07%
Share / Unit	[5],[16],[17],[19]	2,000
Investment, Identifier [Axis]: Summit Materials, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: SupplyOne, Inc.
Schedule of Investments [Line Items]
Interest Rate		10%	[5],[6]	10%	[8],[10]
Interest Rate, PIK		1.50%	[5],[6]	1.50%	[8],[10]
Par Amount / Unit		$ 10,189	[5]	$ 10,113	[8]
Cost		10,189	[5]	10,113	[8]
Fair Value		$ 10,189	[5]	$ 10,113	[8]
% of Net Assets		3.37%	[1],[5]	3.89%	[2],[8]
Investment, Identifier [Axis]: SupplyOne, Inc. 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 504	[5],[16],[17]	$ 504	[8],[14],[15]
Fair Value		$ 812	[5],[16],[17]	$ 980	[8],[14],[15]
% of Net Assets		0.27%	[1],[5],[16],[17]	0.38%	[2],[8],[14],[15]
Share / Unit		1,000	[5],[16],[17]	1	[8],[14],[15]
Investment, Identifier [Axis]: Tempo Acquisition LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Topgolf Callaway Brands Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.50%
Interest Rate	[4],[6],[18],[19]	8.90%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 497
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[5],[6]	11.72%
Par Amount / Unit	[5]	$ 2,532
Cost	[5]	2,487
Fair Value	[5]	$ 2,511
% of Net Assets	[1],[5]	0.83%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.72%
Par Amount / Unit	[4],[5],[12]	$ 1,157
Cost	[4],[5],[12]	(21)
Fair Value	[4],[5],[12]	$ (10)
% of Net Assets	[1],[4],[5],[12]	0%
Investment, Identifier [Axis]: Trench Plate Rental Co.
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 127	[5],[16],[17]	$ 127	[8],[14],[15]
Fair Value		$ 105	[5],[16],[17]	$ 134	[8],[14],[15]
% of Net Assets		0.03%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		1,000	[5],[16],[17]	1	[8],[14],[15]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	6.25%	[7],[8],[10],[13]
Interest Rate		11.65%	[4],[5],[6]	10.84%	[7],[8],[10],[13]
Par Amount / Unit		$ 2,978	[4],[5]	$ 400	[7],[8],[13]
Cost		2,978	[4],[5]	37	[7],[8],[13]
Fair Value		$ 2,919	[4],[5]	$ 32	[7],[8],[13]
% of Net Assets		0.97%	[1],[4],[5]	0.01%	[2],[7],[8],[13]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 398	[4],[5]	$ 3,000	[7],[8]
Cost		398	[4],[5]	3,000	[7],[8]
Fair Value		$ 390	[4],[5]	$ 2,888	[7],[8]
% of Net Assets		0.13%	[1],[4],[5]	1.11%	[2],[7],[8]
Investment, Identifier [Axis]: Trilon Group, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 597	[4],[5]	$ 2,993	[7],[8]
Cost		593	[4],[5]	2,964	[7],[8]
Fair Value		$ 585	[4],[5]	$ 2,881	[7],[8]
% of Net Assets		0.19%	[1],[4],[5]	1.11%	[2],[7],[8]
Investment, Identifier [Axis]: Trilon Group, LLC 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	6.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	10.84%	[7],[8],[10]
Par Amount / Unit		$ 2,970	[4],[5]	$ 600	[7],[8]
Cost		2,944	[4],[5]	594	[7],[8]
Fair Value		$ 2,911	[4],[5]	$ 593	[7],[8]
% of Net Assets		0.96%	[1],[4],[5]	0.23%	[2],[7],[8]
Investment, Identifier [Axis]: Tronox Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.50%
Interest Rate	[4],[6],[18],[19]	8.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	498
Fair Value	[4],[18],[19]	$ 497
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Turbine Engine Specialist, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	950%
Interest Rate	[5],[6]	14.82%
Par Amount / Unit	[5]	$ 1,978
Cost	[5]	1,928
Fair Value	[5]	$ 1,929
% of Net Assets	[1],[5]	0.64%
Investment, Identifier [Axis]: UPC Finance Partnership
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	486
Fair Value	[4],[18],[19]	$ 494
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: US Foods, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 750
Cost	[4],[18],[19]	753
Fair Value	[4],[18],[19]	$ 752
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: US Radiology Specialists, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[6],[11],[18]	5.25%	[7],[9],[10],[24]
Interest Rate		10.65%	[4],[6],[11],[18]	10.02%	[7],[9],[10],[24]
Par Amount / Unit		$ 1,868	[4],[11],[18]	$ 1,882	[7],[9],[24]
Cost		1,794	[4],[11],[18]	1,798	[7],[9],[24]
Fair Value		$ 1,817	[4],[11],[18]	$ 1,704	[7],[9],[24]
% of Net Assets		0.60%	[1],[4],[11],[18]	0.66%	[2],[7],[9],[24]
Investment, Identifier [Axis]: Uber Technologies Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	751
Fair Value	[4],[18],[19]	$ 749
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Ultima Health Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate		11%	[5],[6]	11%	[8],[10]
Interest Rate, PIK		1.50%	[5],[6]	1.50%	[8],[10]
Par Amount / Unit		$ 1,321	[5]	$ 1,306	[8]
Cost		1,298	[5]	1,282	[8]
Fair Value		$ 1,281	[5]	$ 1,278	[8]
% of Net Assets		0.42%	[1],[5]	0.49%	[2],[8]
Investment, Identifier [Axis]: Ultima Health Holdings, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0%
Cost		$ 130	[5],[16],[17]	$ 130	[8],[14],[15]
Fair Value		$ 126	[5],[16],[17]	$ 130	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		11	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: United Airlines Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.75%
Interest Rate	[4],[6],[18],[19]	9.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	753
Fair Value	[4],[18],[19]	$ 750
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Viking Target, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5%	[4],[5],[6]	5%	[7],[8],[10]
Interest Rate		10.32%	[4],[5],[6]	9.77%	[7],[8],[10]
Par Amount / Unit		$ 6,379	[4],[5]	$ 6,945	[7],[8]
Cost		6,360	[4],[5]	6,906	[7],[8]
Fair Value		$ 6,367	[4],[5]	$ 6,916	[7],[8]
% of Net Assets		2.10%	[1],[4],[5]	2.66%	[2],[7],[8]
Investment, Identifier [Axis]: Virgin Media Bristol LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.25%
Interest Rate	[4],[6],[18],[19],[21]	8.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 750
Cost	[4],[18],[19],[21]	743
Fair Value	[4],[18],[19],[21]	$ 734
% of Net Assets	[1],[4],[18],[19],[21]	0.24%
Investment, Identifier [Axis]: W2O Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	4.75%	[7],[8],[10]
Interest Rate		10.72%	[4],[5],[6]	9.52%	[7],[8],[10]
Par Amount / Unit		$ 6,895	[4],[5]	$ 6,947	[7],[8]
Cost		6,895	[4],[5]	6,947	[7],[8]
Fair Value		$ 6,895	[4],[5]	$ 6,905	[7],[8]
% of Net Assets		2.28%	[1],[4],[5]	2.65%	[2],[7],[8]
Investment, Identifier [Axis]: WCI Holdings LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 535
Fair Value	[5],[16],[17],[19]	$ 589
% of Net Assets	[1],[5],[16],[17],[19]	0.19%
Share / Unit	[5],[16],[17],[19]	534,934
Investment, Identifier [Axis]: WSB Engineering Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6%
Interest Rate	[4],[5],[6]	11.40%
Par Amount / Unit	[4],[5]	$ 1,644
Cost	[4],[5]	1,619
Fair Value	[4],[5]	$ 1,619
% of Net Assets	[1],[4],[5]	0.54%
Investment, Identifier [Axis]: WSB Engineering Holdings Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6%
Interest Rate	[4],[5],[6],[12]	11.40%
Par Amount / Unit	[4],[5],[12]	$ 1,096
Cost	[4],[5],[12]	(8)
Fair Value	[4],[5],[12]	$ (16)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Wellspring Pharmaceutical
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6]	5.75%	[7],[8],[10]
Interest Rate		11.47%	[4],[5],[6]	10.53%	[7],[8],[10]
Par Amount / Unit		$ 4,064	[4],[5]	$ 4,095	[7],[8]
Cost		3,995	[4],[5]	4,017	[7],[8]
Fair Value		$ 3,937	[4],[5]	$ 4,020	[7],[8]
% of Net Assets		1.30%	[1],[4],[5]	1.54%	[2],[7],[8]
Investment, Identifier [Axis]: Wellspring Pharmaceutical (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6]	5.75%	[8],[10],[13]
Interest Rate		11.22%	[5],[6]	10.53%	[8],[10],[13]
Par Amount / Unit		$ 1,890	[5]	$ 1,895	[8],[13]
Cost		1,878	[5]	(14)	[8],[13]
Fair Value		$ 1,831	[5]	$ (35)	[8],[13]
% of Net Assets		0.61%	[1],[5]	(0.01%)	[2],[8],[13]
Investment, Identifier [Axis]: WideOpenWest Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	494
Fair Value	[4],[18],[19]	$ 493
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[10]			5%
Interest Rate	[7],[8],[10]			9.59%
Par Amount / Unit	[7],[8]			$ 2,045
Cost	[7],[8]			2,026
Fair Value	[7],[8]			$ 2,026
% of Net Assets	[2],[7],[8]			0.78%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.75%
Interest Rate	[4],[5],[6]	11.15%
Par Amount / Unit	[4],[5]	$ 1,535
Cost	[4],[5]	1,505
Fair Value	[4],[5]	$ 1,520
% of Net Assets	[1],[4],[5]	0.50%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.50%
Interest Rate	[4],[5],[6]	10.90%
Par Amount / Unit	[4],[5]	$ 2,030
Cost	[4],[5]	2,012
Fair Value	[4],[5]	$ 1,991
% of Net Assets	[1],[4],[5]	0.66%
Investment, Identifier [Axis]: Ziggo Financing Partnership
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.50%
Interest Rate	[4],[6],[18],[19],[21]	7.90%
Par Amount / Unit	[4],[18],[19],[21]	$ 500
Cost	[4],[18],[19],[21]	489
Fair Value	[4],[18],[19],[21]	$ 489
% of Net Assets	[1],[4],[18],[19],[21]	0.16%
[1]Percentage is based on net assets of $302,138 as of September 30, 2023.[2]Percentage is based on net assets of $260,301 as of December 31, 2022.[3]Cash equivalents balance represents amounts held in interest-bearing money market funds issued by U.S. Bank National Association and First American.[4] Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 5 “Secured Borrowings” for more information. Investment valued using unobservable inputs (Level 3). See Note 2 Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 5 “Secured Borrowings”. Investment valued using unobservable inputs (Level 3). See Note 2 Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 6 "Commitments and Contingencies". The investment may be subject to unused commitment fees. Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 6 "Commitments and Contingencies". The investment may be subject to unused commitment fees. Investments valued using observable inputs (Level 2), if applicable. See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 3 "Fair Value Measurements" for more information. Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 3 "Fair Value Measurements" for more information.

CONSOLIDATED SCHEDULE OF INVE_2

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED) (Parenthetical) $ in Thousands	Sep. 30, 2023 USD ($) investment		Dec. 31, 2022 USD ($) investment
Schedule of Investments [Line Items]
Net assets	$ 302,138		$ 260,301
Aggregate fair value	$ 9,328		$ 4,338
Percent of net assets	149.33%	[1]	134.27%	[2]
Canada
Schedule of Investments [Line Items]
Percent of net assets	1.79%
Fair value of investments	$ 5,411
Ireland
Schedule of Investments [Line Items]
Percent of net assets	0.41%
Fair value of investments	$ 1,240
Luxembourg
Schedule of Investments [Line Items]
Percent of net assets	0.41%
Fair value of investments	$ 1,239
Netherlands
Schedule of Investments [Line Items]
Percent of net assets	0.16%
Fair value of investments	$ 489
United Kingdom
Schedule of Investments [Line Items]
Percent of net assets	2.86%
Fair value of investments	$ 8,624
Restricted Security
Schedule of Investments [Line Items]
Number of investments | investment	33		17
Percent of net assets	3.09%		1.70%
Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets	70%		70%
Non Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets	8.62%		1.64%
One Month Libor
Schedule of Investments [Line Items]
Effective interest rate			4.39%
Three Month Libor
Schedule of Investments [Line Items]
Effective interest rate			4.77%
One Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.32%		4.36%
Three Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.40%		4.59%
Six Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.47%		4.78%
Twelve Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.47%
[1]Percentage is based on net assets of $302,138 as of September 30, 2023.[2]Percentage is based on net assets of $260,301 as of December 31, 2022.

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	ORGANIZATION Nuveen Churchill Private Capital Income Fund (“PCAP”, and together with its consolidated subsidiaries, the “Fund”) is a Delaware statutory trust formed on February 8, 2022. PCAP is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Fund is externally managed by its adviser, Churchill Asset Management LLC (the “Adviser” or “Churchill”). Churchill is an indirect subsidiary of Nuveen, LLC (“Nuveen”), the investment management division of TIAA (as defined below). Churchill has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or the “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (defined below) pursuant to an investment sub-advisory agreement between the Adviser and Nuveen Asset Management (as discussed further in Note 4 ). The Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) as defined under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Fund’s investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which the Fund defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Fund primarily focuses on investing in U.S. middle market companies with $10 to $100 million in EBITDA, which the Fund considers the core middle market. The Fund primarily invests in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. The portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). Note 7 ), the Fund also will invest 5% to 10% of its assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”). The Fund was established by Teachers Insurance and Annuity Association of America (“TIAA”), the ultimate parent of Churchill and Nuveen, and operated as a wholly owned subsidiary of TIAA until the Escrow Break Date (as defined below). On March 30, 2022, TIAA purchased 40 shares of the Fund’s Class I shares at $25.00 per share. On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In addition, on March 31, 2022, the Fund entered into a promissory note with TIAA (the “Note”) as the lender. The principal amount of the Note equaled (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500 (as discussed further in Note 4 ). In connection therewith, the Fund issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32,731 and $226 of principal and interest, respectively. NCPIF SPV I LLC (“SPV I”), a Delaware limited liability company, formed on February 25, 2022. SPV I is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation. SPV I commenced operations on March 31, 2022, upon receipt of contribution of portfolio investments from TIAA to the Fund (as discussed further in Note 7 ). NCPIF Equity Holdings LLC (“Equity Holdings”), a Delaware limited liability company, was formed on April 1, 2022. Equity Holdings commenced operations on February 6, 2023. Equity Holdings is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within. Consolidation As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash, Restricted Cash and Cash Equivalents Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of September 30, 2023, the Fund did not hold any restricted cash. Valuation of Portfolio Investments Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value. ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below: • Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. • Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. • Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment. Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price. Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs. Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board. With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows: i. the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm; ii. to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board of Trustees to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value; iii. the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and iv. the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith. The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources. When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment. The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such value do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material. The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments. Investment Transactions and Revenue Recognition Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains and losses on investment transactions are determined on a specific identification basis and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments. Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income. The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of September 30, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $67,603 and $70,361, respectively, which represents approximately 15.17% and 20.13% of total investments at fair value, respectively. For the three and nine months ended September 30, 2023, the Company earned $573 and $1,647, respectively, in PIK income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company earned $211 and $450, respectively, in PIK income. As of September 30, 2023 and 2022, there were no PIK loans in the Fund's portfolio on non-accrual status. Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three and nine months ended September 30, 2023, the Company earned $17 and $115, respectively, in dividend income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not earn any dividend income on its equity investments. Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three and nine months ended September 30, 2023, the Company earned other income of $100 and $131, respectively, primarily related to prepayment and amendment fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) to September 30, 2022, the Fund earned other income of $446 and $446, respectively, primarily related to prepayment and amendment fees. Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of September 30, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status. Deferred Financing Costs Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities. Organization and Offering Costs Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 4 for further details on the Expense Support Agreement. Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the three and nine months ended September 30, 2023, offering costs of $326 and $660, respectively, were incurred, and $187 and $468, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, offering costs of $225 and $375, respectively, were incurred, and $78 and $118, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 4 for further details on the Expense Support Agreement. Income Taxes For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute. The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI. In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax. The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three and nine months ended September 30, 2023, the Company did not incur any excise tax expense. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not incur any excise tax expense. Dividends and Distributions to Common Shareholders The Fund has declared distributions each month beginning in September 2022 through the date of this Quarterly Report on Form 10-Q, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any. Functional Currency The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars. Recent Accounting Standards Updates The FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reportin g in March 2020. This update provides temporary optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedge accounting, and other transactions subject to meeting certain criteria. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discounted because of reference rate reform, and was effective upon issuance through December 31, 2022. As of September 30, 2023, the Fund has amended substantially all of its agreements that have LIBOR as a reference rate to an alternate rate. Contract modifications may be required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Fair Value Disclosures The following table presents fair value measurements of investments, by major class as of September 30, 2023 and December 31, 2022, according to the fair value hierarchy: As of September 30, 2023 Level 1 Level 2 Level 3 Total Assets: First Lien Term Loans $ — $ 31,383 $ 310,315 $ 341,698 Subordinated Debt (1) — — 94,751 94,751 Equity Investments — — 9,328 9,328 Cash Equivalents 5,417 — — 5,417 Total $ 5,417 $ 31,383 $ 414,394 $ 451,194 _______________ (1) Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $45,206 and mezzanine debt of $49,545. As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: First Lien Term Loans $ — $ 1,704 $ 249,667 $ 251,371 Subordinated Debt (1) — — 93,809 93,809 Equity Investments — — 4,338 4,338 Total $ — $ 1,704 $ 347,814 $ 349,518 _______________ (1) Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903. The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three and nine months ended September 30, 2023: First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of June 30, 2023 $ 294,555 $ 89,541 $ 5,490 $ 389,586 Purchase of investments 28,637 4,509 3,763 36,909 Proceeds from principal repayments and sales of investments (11,251) — — (11,251) Payment-in-kind interest — 447 — 447 Amortization of premium/accretion of discount, net 67 47 — 114 Net realized gain (loss) on investments 75 — — 75 Net change in unrealized appreciation (depreciation) on investments 34 207 75 316 Transfers out of Level 3 (1) (1,802) — — (1,802) Balance as of September 30, 2023 $ 310,315 $ 94,751 $ 9,328 $ 414,394 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023 $ 53 $ 207 $ 75 $ 335 ________________ (1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company. First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of December 31, 2022 $ 249,668 $ 93,808 $ 4,338 $ 347,814 Purchase of investments 75,150 9,976 5,312 90,438 Proceeds from principal repayments and sales of investments (14,041) (10,212) (392) (24,645) Payment-in-kind interest — 1,521 — 1,521 Amortization of premium/accretion of discount, net 412 185 — 597 Net realized gain (loss) on investments 90 311 291 692 Net change in unrealized appreciation (depreciation) on investments (964) (838) (221) (2,023) Balance as of September 30, 2023 $ 310,315 $ 94,751 $ 9,328 $ 414,394 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023 $ (905) $ (514) $ (45) $ (1,464) The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended September 30, 2022 and for the period February 28, 2022 (inception) through September 30, 2022: First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of June 30, 2022 $ 197,343 $ 94,727 $ 1,725 $ 293,795 Purchase of investments 25,868 3,556 1,002 30,426 Proceeds from principal repayments and sales of investments (1,102) — — (1,102) Payment-in-kind interest — 409 — 409 Amortization of premium/accretion of discount, net 82 52 — 134 Net realized gain (loss) on investments 3 — — 3 Net change in unrealized appreciation (depreciation) on investments (746) (624) 113 (1,257) Balance as of September 30, 2022 $ 221,448 $ 98,120 $ 2,840 $ 322,408 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022 $ (746) $ (624) $ 113 $ (1,257) First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of February 8, 2022 (inception) $ — $ — $ — $ — Purchase of investments 231,983 117,526 2,383 351,892 Proceeds from principal repayments and sales of investments (8,692) (19,000) — (27,692) Payment-in-kind interest — 409 — 409 Amortization of premium/accretion of discount, net 198 127 — 325 Net realized gain (loss) on investments 17 (281) — (264) Net change in unrealized appreciation (depreciation) on investments (2,058) (661) 457 (2,262) Balance as of September 30, 2022 $ 221,448 $ 98,120 $ 2,840 $ 322,408 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022 $ (2,058) $ (661) $ 457 $ (2,262) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, there were no transfers into or out of Level 3. Significant Unobservable Inputs ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of September 30, 2023 and December 31, 2022 were as follows: Investment Type Fair Value at September 30, 2023 Valuation Techniques Unobservable Inputs Ranges Weighted Average First Lien Term Loans $ 258,715 Yield Method Discount Rate 6.13 % 19.50 % 11.72 % First Lien Term Loans 51,600 Recent Transaction Transaction Price 97.08 100.00 99.06 Subordinated Debt 92,577 Yield Method Discount Rate 11.57 % 21.63 % 14.32 % Subordinated Debt 2,174 Recent Transaction Transaction Price 97.27 97.31 97.28 Equity Investments 5,530 Market Approach EBITDA Multiple 3.50 19.50 10.18 Total $ 410,596 Equity investments in the amount of $3,798 at September 30, 2023 have been excluded from the table above as the investments are valued using recent transaction price. Investment Type Fair Value at December 31, 2022 Valuation Techniques Unobservable Inputs Ranges Weighted Average First Lien Term Loans $ 228,304 Yield Method Implied Discount Rate 8.98 % 13.37 % 10.63 % First Lien Term Loans 21,363 Recent Transaction Transaction Price 98.01 98.08 98.05 Subordinated Debt 88,391 Yield Method Implied Discount Rate 8.88 % 17.94 % 13.39 % Subordinated Debt 5,418 Recent Transaction Transaction Price 97.58 98.08 97.82 Equity Investments 3,144 Enterprise Value EBITDA Multiple 9.25x 13.50x 10.93x Total $ 346,620 Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Advisory Agreement On March 31, 2022, the Fund entered into the Advisory Agreement. The Board of Trustees, including all of the trustees who are not “interested persons” (as defined under Section 2(a)(19) of the 1940 Act) of the Fund (the “Independent Trustees”), approved the Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. On August 3, 2022, the Board of Trustees, including all of the Independent Trustees, approved Amendment No. 1 to the Advisory Agreement (the “Advisory Agreement Amendment”), which became effective immediately. The Advisory Agreement Amendment was entered into solely to extend the notice requirement for the Adviser to terminate the Advisory Agreement from 60 days to 120 days (as described below). On January 10, 2023, the Board of Trustees, including all of the Independent Trustees, approved Amendment No. 2 (the “Second Advisory Agreement Amendment”) to the Investment Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into the Second Advisory Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Second Advisory Agreement Amendment, among other things: (1) removed sunset provisions contingent upon recognition of the Common Shares as “covered securities”; (2) removed provisions entitling the Adviser to amounts owed under Sections 3 or Section 7 of the Advisory Agreement following a notice of termination of the Advisory Agreement; (3) specifies the conditions under which the Adviser may sell all or substantially all of the Fund’s assets; and (4) revised provisions to reflect conflicts of interest provisions set forth in the NASAA Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”). On August 2, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 3 (the “Third Advisory Agreement Amendment”) to the Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into Second Advisory Agreement Amendment as a result of comments issued by state securities regulators in connection with their “blue sky” review of the Fund’s offering, and reflects specific language in the Omnibus Guidelines required by a state securities regulator. Unless terminated earlier as described below, the Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board of Trustees or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by the Adviser without penalty upon not less than 120 days’ written notice to the Fund or by the Fund without penalty upon not less than 60 days’ written notice to the Adviser. The holders of a majority of the outstanding voting securities may also terminate either of the Advisory Agreement without penalty. Base Management Fee The management fee is payable monthly in arrears at an annual rate of 0.75% of the value of the Fund’s net assets as of the beginning of the first calendar day of the applicable month. For the first calendar month in which the Fund has operations, net assets will be measured using the beginning net assets as of the Escrow Break Date. In addition, the Adviser has agreed to waive its management fee until the expiry of twelve months from the Escrow Break Date. For the three and nine months ended September 30, 2023, base management fees earned were $547 and $712, respectively, all of which were voluntarily waived by the Adviser. As of September 30, 2023, no amounts were payable to the Adviser related to management fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, no management fees were earned. Incentive Fee The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not: (i) incentive fee on income and (ii) an incentive fee on capital gains. Each part of the incentive fee is outlined below. Incentive Fee Based on Income The portion based on income is based on Pre-Incentive Fee Net Investment Income Returns. “Pre-Incentive Fee Net Investment Income Returns” means, as the context requires, either the dollar value of, or percentage rate of return on the value of net assets at the end of the immediate preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Fund receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee and any shareholder servicing and/or distribution fees). Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments (as discussed further below) are also excluded from Pre-Incentive Fee Net Investment Income Returns. Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediate preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6% annualized). The Fund will pay the Adviser an incentive fee quarterly in arrears with respect to Pre-Incentive Fee Net Investment Income Returns in each calendar quarter as follows: • No incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which our Pre-Incentive Fee Net Investment Income Returns do not exceed the hurdle rate of 1.50% per quarter (6% annualized); • 100% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.76% (7.06% annualized). The Fund refers to this portion of Pre-Incentive Fee Net Investment Income Returns (which exceeds the hurdle rate but is less than 1.76%) as the “catch-up.” The “catch-up” is meant to provide the Adviser with approximately 15% of our Pre-Incentive Fee Net Investment Income Returns as if a hurdle rate did not apply if this net investment income exceeds 1.76% in any calendar quarter; and • 15% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.76% (7.06% annualized). This reflects that once the hurdle rate is reached and the catch-up is achieved, 15% of all Pre-Incentive Fee Net Investment Income Returns thereafter are allocated to the Adviser. These calculations will be pro-rated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter. The Adviser has agreed to waive the incentive fee based on income until the expiry of twelve months from the Escrow Break Date. For the three and nine months ended September 30, 2023, income based incentive fees were $1,219 and $1,592, respectively, all of which were voluntarily waived by the Adviser. As of September 30, 2023, no amounts were payable to the Adviser related to income based incentive fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, no income based incentive fees were earned. Incentive Fee Based on Capital Gains The second component of the incentive fee, the capital gains incentive fee, will be payable at the end of each calendar year in arrears. The amount payable will equal: • 15% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fee on capital gains as calculated in accordance with U.S. GAAP. Each year, the fee paid for the capital gains incentive fee will be net of the aggregate amount of any previously paid capital gains incentive fee for all prior periods. The Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund was to sell the relevant investment and realize a capital gain. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof. The fees that are payable under the Advisory Agreement for any partial period will be appropriately prorated. For the three and nine months ended September 30, 2023, for the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Fund did not incur any incentive fee based on capital gains. Sub-Advisory Agreement On March 31, 2022, the Adviser entered into the Investment Sub-Advisory Agreement with the Sub-Adviser (the “Sub-Advisory Agreement”). The Board of Trustees, including all of the Independent Trustees, also approved the Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. The Sub-Adviser manages certain of the Liquid Investments pursuant to the Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Fund and manages the capital structure of the Fund, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Fund’s performance under the terms of the Investment Advisory Agreement. The Adviser will pay the Sub-Adviser monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by the Sub-Adviser pursuant to the Sub-Advisory Agreement. On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Sub-Advisory Agreement (the “Sub-Advisory Agreement Amendment”), which became effective immediately. The Sub-Advisory Agreement Amendment was entered into solely to extend the notice requirement applicable to both the Adviser and the Sub-Adviser to terminate the Sub-Advisory Agreement from 60 days to 120 days (as described below). Unless terminated earlier as described below, the Sub-Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board of Trustees or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Sub-Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by either the Adviser or the Sub-Adviser without penalty upon not less than 120 days’ written notice to the other. Administration Agreement On March 31, 2022, the Fund entered into an administration agreement with the Administrator (the “Administration Agreement”), which was approved by the Board of Trustees. Pursuant to the Administration Agreement, the Administrator furnishes the Fund with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Fund with the preparation of the financial records that the Fund is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or the Sub-Adviser, the Administrator also may provide significant managerial assistance on the Fund’s behalf to those portfolio companies that have accepted the Fund’s offer to provide such assistance. U.S. Bancorp Fund Services, LLC will provide the Fund with certain fund administration and bookkeeping services pursuant to a sub-administration agreement (the “Sub-Administration Agreement”) with the Administrator. On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 1 (the “Administration Agreement Amendment”) to the Administration Agreement, which became effective immediately. The Fund and the Administrator entered into the Administration Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Administration Agreement Amendment provides that the Indemnified Parties (as defined in the Administration Agreement) will not be entitled to indemnification for any loss or liability to the Fund or its shareholders by reason of the Indemnified Parties’ negligence or misconduct, in accordance with the Omnibus Guidelines. For the three and nine months ended September 30, 2023, the Fund incurred $124 and $362, respectively, in fees under the Sub-Administrative Agreement, which are included in administration fees in the consolidated statement of operations. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company incurred $74 and $149, respectively, in fees under the Sub-Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of September 30, 2023 and December 31, 2022, $505 and $246, respectively, was unpaid and included in accounts payable and accrued expenses in the consolidated statement of assets and liabilities. Intermediary Manager Agreement On March 31, 2022, the Fund entered into an Intermediary Manager Agreement (the “Intermediary Manager Agreement”) with the Intermediary Manager, an affiliate of the Adviser. Under the terms of the Intermediary Manager Agreement, the Intermediary Manager serves as the agent and principal distributor for the Fund’s public offering of its Common Shares. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.85% of the value of the Fund’s net assets attributable to Class S shares as of the beginning of the first calendar day of the month. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.25% of the value of the Fund’s net assets attributable to Class D shares as of the beginning of the first calendar day of the month. No distribution and/or shareholder servicing fees will be paid with respect to Class I shares. The Fund will cease paying the distribution and/or shareholder servicing fees on any Class S share and Class D share in a shareholder’s account at the end of the month in which the Intermediary Manager in conjunction with the transfer agent determines that total brokerage commissions and distribution and/or shareholder servicing fees paid with respect to any such share held by such shareholder within such account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such share. At the end of such month, each such Class S share or Class D share will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such share. The total underwriting compensation and total organization and offering expenses will not exceed 10% and 15%, respectively, of the gross proceeds from the offering. The Intermediary Manager Agreement may be terminated at any time, without the payment of any penalty, by vote of a majority of the Independent Trustees and the trustees who have no direct or indirect financial interest in the operation of the Fund’s distribution plan or the Intermediary Manager Agreement or by vote a majority of the outstanding voting securities of the Fund, on not more than 60 days’ written notice to the Intermediary Manager or the Adviser. The Intermediary Manager Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act. Expense Support and Conditional Reimbursement Agreement On March 31, 2022, the Fund entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement provides that, Nuveen Alternative Holdings, an affiliate of the Adviser may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, provided that no portion of the payment will be used to pay any interest expenses of the Fund and/or shareholder servicing fees of the Fund (each, an “Expense Payment’). Such expense payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from the Fund to Nuveen Alternative Holdings. Following any calendar quarter in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Fund’s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (such amount referred to as the “Excess Operating Funds”), the Fund will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings until such time as all Expense Payments made by the entity to the Fund within three years prior to the last business day of such calendar quarter have been reimbursed. Available Operating Funds means the sum of (i) the Fund’s net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) the Fund’s net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to the Fund on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar quarter will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to the Fund within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by the Fund to Nuveen Alternative Holdings. No Reimbursement Payment for any month will be made if (1) the annualized rate of regular cash distributions declared by the Fund at the time of such Reimbursement Payment is less than the annualized rate of regular cash distributions declared by the Fund at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The Operating Expense Ratio is calculated by dividing the Fund’s operating costs and expenses incurred, less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets. The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month. The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees: For the Quarter Ended Expense Payments by Adviser Reimbursement Payments to Adviser Unreimbursed Expense Payments Reimbursement Eligibility Expiration March 31, 2022 $ 983 $ — $ 983 March 31, 2025 June 30, 2022 677 — 677 June 30, 2025 September 30, 2022 379 — 379 September 30, 2025 December 31, 2022 176 — 176 December 31, 2025 March 31, 2023 198 — 198 March 31, 2026 June 30, 2023 113 — 113 June 30, 2026 September 30, 2023 327 — 327 September 30, 2026 Total $ 2,853 $ — $ 2,853 Board of Trustees’ Fees The Board consists of seven members, four of whom are Independent Trustees. On March 30, 2022, the Board established an Audit Committee, a Nominating and Corporate Governance Committee and a Special Transactions Committee, each consisting solely of the Independent Trustees, and may establish additional committees in the future. For the three and nine months ended September 30, 2023, the Fund incurred $128 and $380, respectively, in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, the Fund incurred $128 and $257, respectively, in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. As of September 30, 2023 and December 31, 2022, $128 and $128, respectively, were unpaid and are included in Board of Trustees’ fees payable in the accompanying consolidated statements of assets and liabilities. Other Related Party Transactions From time to time, the Adviser may pay amounts owed by the Fund to third-party providers of goods or services and the Fund will subsequently reimburse the Adviser for such amounts paid on its behalf. Amounts payable to the Adviser are settled in the normal course of business without formal payment terms. As of September 30, 2023 and December 31, 2022, the Fund owed the Adviser $344 and $231, respectively, for reimbursements including the Fund’s allocable portion of overhead, which is included in accounts payable and accrued expenses in the accompanying consolidated statement of assets and liabilities. Promissory Note On March 31, 2022, the Fund entered into the Note with TIAA as the lender. The Note is issued under the purchase and sales agreement, dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund (as discussed further in Note 7 ). The principal amount of the Note equals (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly. On June 3, 2022, the Fund fully repaid the balance on the Note which was comprised of $32,731 and $226 of principal and interest, respectively.

SECURED BORROWINGS

SECURED BORROWINGS	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
SECURED BORROWINGS	SECURED BORROWINGS In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. As of September 30, 2023 and December 31, 2022, the Fund’s asset coverage was 350.22% and 267.94%, respectively. On April 19, 2022, SPV I entered into a credit agreement with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”). On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200,000 to $250,000; and (ii) increased the rate to be paid from Daily SOFR +2.00% to Daily SOFR +2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR +2.15% to Daily SOFR +2.40%, as reflected in the Amendment. Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions . As of September 30, 2023, the Bank of America Credit Facility bears interest at a rate of Daily SOFR plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act. Prior to entering into the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement. The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of September 30, 2023, approximates its carrying value. The carrying amounts of the Fund’s assets and liabilities, including the credit facilities, other than investments at fair value, approximate fair value due to their short maturities. The borrowing consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 Bank of America Credit Facility Total Total Commitment $ 250,000 $ 250,000 Borrowings Outstanding (1) 120,750 120,750 Unused Portion (2) 129,250 129,250 Amount Available (3) 103,112 103,112 _______________ (1) Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs. (2) The unused portion is the amount upon which commitment fees are based. (3) Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios. December 31, 2022 Bank of America Credit Facility Total Total Commitment $ 250,000 $ 250,000 Borrowings Outstanding (1) 155,000 155,000 Unused Portion (2) 95,000 95,000 Amount Available (3) 81,855 81,855 ______________ (1) Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs. (2) The unused portion is the amount upon which commitment fees are based. (3) Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios. For the three and nine months ended September 30, 2023 and for the three months ended September 30, 2022 and from February 8, 2022 (inception) through September 30, 2022, the components of interest expense and debt financing expenses were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (1) Borrowing interest expense $ 2,469 $ 1,189 $ 7,238 $ 1,654 Unused fees 124 117 351 203 Amortization of deferred financing costs (2) 44 19 122 35 Total interest and debt financing expenses $ 2,637 $ 1,325 $ 7,711 $ 1,892 Average interest rate (3) 8.02 % 4.67 % 7.57 % 4.01 % Average daily borrowings $ 128,192 $ 110,788 $ 133,903 $ 102,442 _______________ (1) Period from February 8, 2022 (inception) through September 30, 2022. (2) For the three and nine months ended September 30, 2023, $0 and $2, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the three and nine months ended September 30, 2022, $373 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. (3) Average interest rate includes interest expense and unused fees.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIESIn the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Fund. The Fund believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of September 30, 2023 for any such exposure. As of September 30, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans: Portfolio Company September 30, 2023 December 31, 2022 Acclaim MidCo $ 891 $ — ADPD Holdings, LLC 1,919 2,149 ASTP Holdings Co-Investment LP 26 — Chroma Color Corporation 381 — COP Exterminators 503 — Evergreen Services Group, LLC — 267 Health Management Associates 415 — Heartland Veterinary Partners, LLC 2,210 5,000 Impact Parent Corporation 1,832 — Infobase Acquisition, Inc. 122 122 INS Intermediate 1,139 — ISG Merger Sub, LLC 766 1,282 ITSavvy, LLC 36 480 Kenco Group, Inc. 850 850 Keng Acquisition 2,041 — KL Bronco Acquisition, Inc. 599 599 KRIV Acquisition 779 — Legacy Service Partners 479 — LMI Consulting, LLC 2 — MEI Rigging & Crating 501 — Omnia Partners 129 — Orion Group 2,571 — Ovation Holdings, Inc. 470 — Palmetto AcquisitionCo 1,217 — Patriot Growth Insurance Service 2,091 5,568 Perennial Services 1,319 — Pinnacle Supply Partners 1,455 — Randys Holdings, Inc 1,332 1,332 RTH 323 — SCP Eye Care Holdco, LLC 386 735 Transit Buyer LLC 1,157 — Trilon Group, LLC — 363 Victors CCC Buyer LLC 560 560 Wellspring Pharmaceutical — 1,895 WSB Engineering Holdings 1,096 — Total unfunded commitments $ 29,597 $ 21,202 The Fund believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of September 30, 2023, the Fund had cash and cash equivalents of $6,344 and available borrowings under the Bank of America Credit Facility of $103,112.

NET ASSETS

NET ASSETS	9 Months Ended
	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
NET ASSETS	NET ASSETS In connection with its formation, the Fund has the authority to issue an unlimited number of Common Shares. On March 30, 2022, an affiliate of the Adviser, TIAA, purchased 40 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. On March 31, 2022, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In connection therewith, the Fund entered into the Note with TIAA as the lender (as described in Note 4 ), and issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. The Fund fully repaid the balance of the Note to TIAA on June 3, 2022. On the Escrow Break Date, the Fund had satisfied the minimum offering requirement and the Board authorized the release of proceeds from escrow. During the nine months ending September 30, 2023, the Fund issued 1,735,030 Class I shares for total proceeds of $42,690. As of September 30, 2023, the Fund has not repurchased any Class I shares and has not issued any Class S or D shares. As of September 30, 2023, the Fund recorded $1,145 as a result of excess capital funding received in connection with its September capital contributions, this amount is included in due to transfer agent on the statement of assets and liabilities. Distributions The following table summarizes the Fund’s dividends declared for the period from February 8, 2022 (inception) through September 30, 2023. Class I Declaration Date Record Date Payment Date Dividend per Share Distribution Amount September 30, 2022 September 30, 2022 October 28, 2022 $0.870 (1) $9,170 October 31, 2022 October 31, 2022 November 28, 2022 $0.180 $1,897 November 30, 2022 November 30, 2022 December 28, 2022 $0.190 $2,003 December 31, 2022 December 31, 2022 January 28, 2023 $0.295 (2) $3,109 January 31, 2023 January 31, 2023 February 28, 2023 $0.200 $2,108 February 28, 2023 February 28, 2023 March 28, 2023 $0.200 $2,108 March 31, 2023 March 31, 2023 April 28, 2023 $0.230 $2,424 April 28, 2023 April 30, 2023 May 26, 2023 $0.240 $2,530 May 25, 2023 May 31, 2023 June 28, 2023 $0.240 $2,530 June 28, 2023 June 30, 2023 July 28, 2023 $0.240 $2,605 July 28, 2023 July 31, 2023 August 28, 2023 $0.270 (3) $3,081 August 23, 2023 August 31, 2023 September 28, 2023 $0.270 (3) $3,133 September 29, 2023 September 30, 2023 October 27, 2023 $0.250 $3,070 _______________ (1) Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022. (2) Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income. (3) Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income and capital gain. Distribution Reinvestment Plan The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board of Trustees on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board of Trustees authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places. The following table reflects the shares issued pursuant to the distribution reinvestment plan from inception through September 30, 2023. Class I Declaration Date Record Date Payment Date Shares Issued June 28, 2023 June 30, 2023 July 28, 2023 573 July 28, 2023 July 31, 2023 August 28, 2023 1,426 August 23, 2023 August 31, 2023 September 28, 2023 2,316 Share Repurchase Program Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board of Trustees, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board of Trustees, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board of Trustees will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued Common Shares. Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders.Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program. Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board of Trustees, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits. For the nine months ended September 30, 2023, no Common Shares were repurchased.

CONSOLIDATED FINANCIAL HIGHLIGH

CONSOLIDATED FINANCIAL HIGHLIGHTS	9 Months Ended
	Sep. 30, 2023
Investment Company [Abstract]
CONSOLIDATED FINANCIAL HIGHLIGHTS	CONSOLIDATED FINANCIAL HIGHLIGHTS The following is a schedule of financial highlights for the nine months ended September 30, 2023 and for the period from February 8, 2022 (inception) through September 30, 2022: Nine Months Ended September 30, 2023 2022 * Per share data: Net asset value at beginning of period $ 24.70 $ — Net investment income (loss) 2.18 0.99 Net realized gains (losses) (1) 0.06 (0.02) Net change in unrealized appreciation (depreciation) (1) (0.18) (0.22) Net increase (decrease) in net assets resulting from operations 2.06 0.75 Stockholder distributions from income (2) (2.14) (0.87) Issuance of common shares — 25.00 Other (3) (0.01) — Net asset value at end of period $ 24.61 $ 24.88 Supplemental Data: Net assets at end of period $ 302,138 $ 262,221 Shares outstanding at end of period (1) 12,279,386 10,540,040 Total return 8.63 % 2.93 % Ratio to average net assets: Ratio of net expenses to average net assets (4) (5) 4.73 % 1.82 % Ratio of net investment income (loss) to average net assets (4) 11.75 % 6.17 % Portfolio turnover rate (6) 6.36 % 9.10 % Asset coverage ratio 350.22 % 309.78 % _______________ *For the period February 8, 2022 (inception) through September 30, 2022 (1) The per share data was derived by using the weighted average shares outstanding during the period. (2) The per share data for distributions reflects the actual amount of distributions declared during the period. (3) Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date. (4) Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 6.48% and 2.43% for the period ending September 30, 2023 and for the period September 30, 2022, respectively, on an annualized basis, excluding the effect of expense support which represented (0.27)% and (0.61)%, respectively, of average net assets, and excluding the effect of waived management fees and incentive fees which represented (0.45)% and (1.03)% of average net assets for the period ending September 30, 2023. There were no management fees or incentive fees incurred or waived for the period February 8, 2022 (inception) through September 30, 2022. Average net assets is calculated utilizing quarterly net assets. (5) The ratio of interest and debt financing expenses to average net assets for the period ending September 30, 2023 and the period February 8, 2022 (inception) through September 30, 2022, was 3.78% and 1.11%%, respectively, Average net assets is calculated utilizing quarterly net assets. (6) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Fund’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of September 30, 2023, except as discussed below. On October 27, 2023, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on November 28, 2023 to shareholders of record as of October 31, 2023. Gross Distribution Shareholder Servicing Fee Net Distribution Class I Common Shares $0.250 $— $0.250 Class S Common Shares $0.250 $0.017 $0.233 Class D Common Shares $0.250 $0.005 $0.245

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 9,065	$ 4,088	$ 7,890	[1]	$ 22,629
[1]Period from February 8, 2022 (inception) through September 30, 2022.

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.
Consolidation	Consolidation As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash, Restricted Cash and Cash Equivalents	Cash, Restricted Cash and Cash Equivalents Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of September 30, 2023, the Fund did not hold any restricted cash.
Valuation of Portfolio Investments	Valuation of Portfolio Investments Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value. ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below: • Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. • Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. • Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment. Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price. Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs. Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board. With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows: i. the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm; ii. to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board of Trustees to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value; iii. the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and iv. the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith. The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources. When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment. The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such value do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material. The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.
Investment Transactions	Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains and losses on investment transactions are determined on a specific identification basis and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments.
Revenue Recognition	Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income. The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of September 30, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $67,603 and $70,361, respectively, which represents approximately 15.17% and 20.13% of total investments at fair value, respectively. For the three and nine months ended September 30, 2023, the Company earned $573 and $1,647, respectively, in PIK income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company earned $211 and $450, respectively, in PIK income. As of September 30, 2023 and 2022, there were no PIK loans in the Fund's portfolio on non-accrual status. Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three and nine months ended September 30, 2023, the Company earned $17 and $115, respectively, in dividend income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not earn any dividend income on its equity investments. Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three and nine months ended September 30, 2023, the Company earned other income of $100 and $131, respectively, primarily related to prepayment and amendment fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) to September 30, 2022, the Fund earned other income of $446 and $446, respectively, primarily related to prepayment and amendment fees. Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of September 30, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.
Deferred Financing Costs	Deferred Financing Costs Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.
Organization and Offering Costs	Organization and Offering Costs Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 4 for further details on the Expense Support Agreement. Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the three and nine months ended September 30, 2023, offering costs of $326 and $660, respectively, were incurred, and $187 and $468, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, offering costs of $225 and $375, respectively, were incurred, and $78 and $118, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 4 for further details on the Expense Support Agreement.
Income Taxes	Income Taxes For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute. The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI. In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax. The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three and nine months ended September 30, 2023, the Company did not incur any excise tax expense. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not incur any excise tax expense.
Dividends and Distributions to Common Shareholders	Dividends and Distributions to Common Shareholders The Fund has declared distributions each month beginning in September 2022 through the date of this Quarterly Report on Form 10-Q, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.
Functional Currency	Functional Currency The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.
Recent Accounting Standards Updates	Recent Accounting Standards Updates The FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reportin g in March 2020. This update provides temporary optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedge accounting, and other transactions subject to meeting certain criteria. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discounted because of reference rate reform, and was effective upon issuance through December 31, 2022. As of September 30, 2023, the Fund has amended substantially all of its agreements that have LIBOR as a reference rate to an alternate rate. Contract modifications may be required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements of Investments	The following table presents fair value measurements of investments, by major class as of September 30, 2023 and December 31, 2022, according to the fair value hierarchy: As of September 30, 2023 Level 1 Level 2 Level 3 Total Assets: First Lien Term Loans $ — $ 31,383 $ 310,315 $ 341,698 Subordinated Debt (1) — — 94,751 94,751 Equity Investments — — 9,328 9,328 Cash Equivalents 5,417 — — 5,417 Total $ 5,417 $ 31,383 $ 414,394 $ 451,194 _______________ (1) Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $45,206 and mezzanine debt of $49,545. As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: First Lien Term Loans $ — $ 1,704 $ 249,667 $ 251,371 Subordinated Debt (1) — — 93,809 93,809 Equity Investments — — 4,338 4,338 Total $ — $ 1,704 $ 347,814 $ 349,518 _______________ (1) Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.
Schedule of Reconciliation of the Beginning and Ending Balances for Investments and Fair value Debt Obligations	The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three and nine months ended September 30, 2023: First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of June 30, 2023 $ 294,555 $ 89,541 $ 5,490 $ 389,586 Purchase of investments 28,637 4,509 3,763 36,909 Proceeds from principal repayments and sales of investments (11,251) — — (11,251) Payment-in-kind interest — 447 — 447 Amortization of premium/accretion of discount, net 67 47 — 114 Net realized gain (loss) on investments 75 — — 75 Net change in unrealized appreciation (depreciation) on investments 34 207 75 316 Transfers out of Level 3 (1) (1,802) — — (1,802) Balance as of September 30, 2023 $ 310,315 $ 94,751 $ 9,328 $ 414,394 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023 $ 53 $ 207 $ 75 $ 335 ________________ (1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company. First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of December 31, 2022 $ 249,668 $ 93,808 $ 4,338 $ 347,814 Purchase of investments 75,150 9,976 5,312 90,438 Proceeds from principal repayments and sales of investments (14,041) (10,212) (392) (24,645) Payment-in-kind interest — 1,521 — 1,521 Amortization of premium/accretion of discount, net 412 185 — 597 Net realized gain (loss) on investments 90 311 291 692 Net change in unrealized appreciation (depreciation) on investments (964) (838) (221) (2,023) Balance as of September 30, 2023 $ 310,315 $ 94,751 $ 9,328 $ 414,394 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023 $ (905) $ (514) $ (45) $ (1,464) The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended September 30, 2022 and for the period February 28, 2022 (inception) through September 30, 2022: First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of June 30, 2022 $ 197,343 $ 94,727 $ 1,725 $ 293,795 Purchase of investments 25,868 3,556 1,002 30,426 Proceeds from principal repayments and sales of investments (1,102) — — (1,102) Payment-in-kind interest — 409 — 409 Amortization of premium/accretion of discount, net 82 52 — 134 Net realized gain (loss) on investments 3 — — 3 Net change in unrealized appreciation (depreciation) on investments (746) (624) 113 (1,257) Balance as of September 30, 2022 $ 221,448 $ 98,120 $ 2,840 $ 322,408 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022 $ (746) $ (624) $ 113 $ (1,257) First Lien Term Loans Subordinated Debt Equity Investments Total Balance as of February 8, 2022 (inception) $ — $ — $ — $ — Purchase of investments 231,983 117,526 2,383 351,892 Proceeds from principal repayments and sales of investments (8,692) (19,000) — (27,692) Payment-in-kind interest — 409 — 409 Amortization of premium/accretion of discount, net 198 127 — 325 Net realized gain (loss) on investments 17 (281) — (264) Net change in unrealized appreciation (depreciation) on investments (2,058) (661) 457 (2,262) Balance as of September 30, 2022 $ 221,448 $ 98,120 $ 2,840 $ 322,408 Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022 $ (2,058) $ (661) $ 457 $ (2,262)
Schedule of Fair Value Measurement Inputs and Valuation Techniques	The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of September 30, 2023 and December 31, 2022 were as follows: Investment Type Fair Value at September 30, 2023 Valuation Techniques Unobservable Inputs Ranges Weighted Average First Lien Term Loans $ 258,715 Yield Method Discount Rate 6.13 % 19.50 % 11.72 % First Lien Term Loans 51,600 Recent Transaction Transaction Price 97.08 100.00 99.06 Subordinated Debt 92,577 Yield Method Discount Rate 11.57 % 21.63 % 14.32 % Subordinated Debt 2,174 Recent Transaction Transaction Price 97.27 97.31 97.28 Equity Investments 5,530 Market Approach EBITDA Multiple 3.50 19.50 10.18 Total $ 410,596 Equity investments in the amount of $3,798 at September 30, 2023 have been excluded from the table above as the investments are valued using recent transaction price. Investment Type Fair Value at December 31, 2022 Valuation Techniques Unobservable Inputs Ranges Weighted Average First Lien Term Loans $ 228,304 Yield Method Implied Discount Rate 8.98 % 13.37 % 10.63 % First Lien Term Loans 21,363 Recent Transaction Transaction Price 98.01 98.08 98.05 Subordinated Debt 88,391 Yield Method Implied Discount Rate 8.88 % 17.94 % 13.39 % Subordinated Debt 5,418 Recent Transaction Transaction Price 97.58 98.08 97.82 Equity Investments 3,144 Enterprise Value EBITDA Multiple 9.25x 13.50x 10.93x Total $ 346,620 Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Schedule of Expenses Reimbursed by the Advisor	The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees: For the Quarter Ended Expense Payments by Adviser Reimbursement Payments to Adviser Unreimbursed Expense Payments Reimbursement Eligibility Expiration March 31, 2022 $ 983 $ — $ 983 March 31, 2025 June 30, 2022 677 — 677 June 30, 2025 September 30, 2022 379 — 379 September 30, 2025 December 31, 2022 176 — 176 December 31, 2025 March 31, 2023 198 — 198 March 31, 2026 June 30, 2023 113 — 113 June 30, 2026 September 30, 2023 327 — 327 September 30, 2026 Total $ 2,853 $ — $ 2,853

SECURED BORROWINGS (Tables)

SECURED BORROWINGS (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Borrowings	The borrowing consisted of the following as of September 30, 2023 and December 31, 2022: September 30, 2023 Bank of America Credit Facility Total Total Commitment $ 250,000 $ 250,000 Borrowings Outstanding (1) 120,750 120,750 Unused Portion (2) 129,250 129,250 Amount Available (3) 103,112 103,112 _______________ (1) Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs. (2) The unused portion is the amount upon which commitment fees are based. (3) Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios. December 31, 2022 Bank of America Credit Facility Total Total Commitment $ 250,000 $ 250,000 Borrowings Outstanding (1) 155,000 155,000 Unused Portion (2) 95,000 95,000 Amount Available (3) 81,855 81,855 ______________ (1) Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs. (2) The unused portion is the amount upon which commitment fees are based. (3) Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios. For the three and nine months ended September 30, 2023 and for the three months ended September 30, 2022 and from February 8, 2022 (inception) through September 30, 2022, the components of interest expense and debt financing expenses were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 (1) Borrowing interest expense $ 2,469 $ 1,189 $ 7,238 $ 1,654 Unused fees 124 117 351 203 Amortization of deferred financing costs (2) 44 19 122 35 Total interest and debt financing expenses $ 2,637 $ 1,325 $ 7,711 $ 1,892 Average interest rate (3) 8.02 % 4.67 % 7.57 % 4.01 % Average daily borrowings $ 128,192 $ 110,788 $ 133,903 $ 102,442 _______________ (1) Period from February 8, 2022 (inception) through September 30, 2022. (2) For the three and nine months ended September 30, 2023, $0 and $2, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the three and nine months ended September 30, 2022, $373 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. (3) Average interest rate includes interest expense and unused fees.

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Unfunded Commitments to Fund Delayed Draw Loans	As of September 30, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans: Portfolio Company September 30, 2023 December 31, 2022 Acclaim MidCo $ 891 $ — ADPD Holdings, LLC 1,919 2,149 ASTP Holdings Co-Investment LP 26 — Chroma Color Corporation 381 — COP Exterminators 503 — Evergreen Services Group, LLC — 267 Health Management Associates 415 — Heartland Veterinary Partners, LLC 2,210 5,000 Impact Parent Corporation 1,832 — Infobase Acquisition, Inc. 122 122 INS Intermediate 1,139 — ISG Merger Sub, LLC 766 1,282 ITSavvy, LLC 36 480 Kenco Group, Inc. 850 850 Keng Acquisition 2,041 — KL Bronco Acquisition, Inc. 599 599 KRIV Acquisition 779 — Legacy Service Partners 479 — LMI Consulting, LLC 2 — MEI Rigging & Crating 501 — Omnia Partners 129 — Orion Group 2,571 — Ovation Holdings, Inc. 470 — Palmetto AcquisitionCo 1,217 — Patriot Growth Insurance Service 2,091 5,568 Perennial Services 1,319 — Pinnacle Supply Partners 1,455 — Randys Holdings, Inc 1,332 1,332 RTH 323 — SCP Eye Care Holdco, LLC 386 735 Transit Buyer LLC 1,157 — Trilon Group, LLC — 363 Victors CCC Buyer LLC 560 560 Wellspring Pharmaceutical — 1,895 WSB Engineering Holdings 1,096 — Total unfunded commitments $ 29,597 $ 21,202

NET ASSETS (Tables)

NET ASSETS (Tables)	9 Months Ended
	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
Schedule of Fund's Dividends Declared	The following table summarizes the Fund’s dividends declared for the period from February 8, 2022 (inception) through September 30, 2023. Class I Declaration Date Record Date Payment Date Dividend per Share Distribution Amount September 30, 2022 September 30, 2022 October 28, 2022 $0.870 (1) $9,170 October 31, 2022 October 31, 2022 November 28, 2022 $0.180 $1,897 November 30, 2022 November 30, 2022 December 28, 2022 $0.190 $2,003 December 31, 2022 December 31, 2022 January 28, 2023 $0.295 (2) $3,109 January 31, 2023 January 31, 2023 February 28, 2023 $0.200 $2,108 February 28, 2023 February 28, 2023 March 28, 2023 $0.200 $2,108 March 31, 2023 March 31, 2023 April 28, 2023 $0.230 $2,424 April 28, 2023 April 30, 2023 May 26, 2023 $0.240 $2,530 May 25, 2023 May 31, 2023 June 28, 2023 $0.240 $2,530 June 28, 2023 June 30, 2023 July 28, 2023 $0.240 $2,605 July 28, 2023 July 31, 2023 August 28, 2023 $0.270 (3) $3,081 August 23, 2023 August 31, 2023 September 28, 2023 $0.270 (3) $3,133 September 29, 2023 September 30, 2023 October 27, 2023 $0.250 $3,070 _______________ (1) Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022. (2) Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income. (3) Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income and capital gain.
Schedule of Shares Issued	The following table reflects the shares issued pursuant to the distribution reinvestment plan from inception through September 30, 2023. Class I Declaration Date Record Date Payment Date Shares Issued June 28, 2023 June 30, 2023 July 28, 2023 573 July 28, 2023 July 31, 2023 August 28, 2023 1,426 August 23, 2023 August 31, 2023 September 28, 2023 2,316

CONSOLIDATED FINANCIAL HIGHLI_2

CONSOLIDATED FINANCIAL HIGHLIGHTS (Tables)	9 Months Ended
	Sep. 30, 2023
Investment Company [Abstract]
Schedule of Financial Highlights	The following is a schedule of financial highlights for the nine months ended September 30, 2023 and for the period from February 8, 2022 (inception) through September 30, 2022: Nine Months Ended September 30, 2023 2022 * Per share data: Net asset value at beginning of period $ 24.70 $ — Net investment income (loss) 2.18 0.99 Net realized gains (losses) (1) 0.06 (0.02) Net change in unrealized appreciation (depreciation) (1) (0.18) (0.22) Net increase (decrease) in net assets resulting from operations 2.06 0.75 Stockholder distributions from income (2) (2.14) (0.87) Issuance of common shares — 25.00 Other (3) (0.01) — Net asset value at end of period $ 24.61 $ 24.88 Supplemental Data: Net assets at end of period $ 302,138 $ 262,221 Shares outstanding at end of period (1) 12,279,386 10,540,040 Total return 8.63 % 2.93 % Ratio to average net assets: Ratio of net expenses to average net assets (4) (5) 4.73 % 1.82 % Ratio of net investment income (loss) to average net assets (4) 11.75 % 6.17 % Portfolio turnover rate (6) 6.36 % 9.10 % Asset coverage ratio 350.22 % 309.78 % _______________ *For the period February 8, 2022 (inception) through September 30, 2022 (1) The per share data was derived by using the weighted average shares outstanding during the period. (2) The per share data for distributions reflects the actual amount of distributions declared during the period. (3) Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date. (4) Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 6.48% and 2.43% for the period ending September 30, 2023 and for the period September 30, 2022, respectively, on an annualized basis, excluding the effect of expense support which represented (0.27)% and (0.61)%, respectively, of average net assets, and excluding the effect of waived management fees and incentive fees which represented (0.45)% and (1.03)% of average net assets for the period ending September 30, 2023. There were no management fees or incentive fees incurred or waived for the period February 8, 2022 (inception) through September 30, 2022. Average net assets is calculated utilizing quarterly net assets. (5) The ratio of interest and debt financing expenses to average net assets for the period ending September 30, 2023 and the period February 8, 2022 (inception) through September 30, 2022, was 3.78% and 1.11%%, respectively, Average net assets is calculated utilizing quarterly net assets. (6) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

SUBSEQUENT EVENTS (Tables)

SUBSEQUENT EVENTS (Tables)	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Schedule of Aggregate Distributions Declared for Each Class of Common Share	On October 27, 2023, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on November 28, 2023 to shareholders of record as of October 31, 2023. Gross Distribution Shareholder Servicing Fee Net Distribution Class I Common Shares $0.250 $— $0.250 Class S Common Shares $0.250 $0.017 $0.233 Class D Common Shares $0.250 $0.005 $0.245

ORGANIZATION (Details)

ORGANIZATION (Details) - USD ($) $ / shares in Units, $ in Thousands				9 Months Ended
	Jun. 03, 2022	Mar. 31, 2022	Mar. 30, 2022	Sep. 30, 2023	Jun. 30, 2022
Schedule of Equity Method Investments [Line Items]
Sale of stock				$ 2,500,000
Class I Common Shares
Schedule of Equity Method Investments [Line Items]
Issuance of shares (in shares)				1,735,030
TIAA
Schedule of Equity Method Investments [Line Items]
Portfolio investments to the fund amount					$ 296,231
TIAA | Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Capital commitments		$ 263,500
Debt instrument, periodic payment, principal	$ 32,731
Debt instrument, periodic payment, interest	$ 226
TIAA | Class I Common Shares
Schedule of Equity Method Investments [Line Items]
Purchased and sold shares (in share)			40
Issuance Price per share (in dollars per share)			$ 25
Issuance of shares (in shares)		10,540,000
Shares issued price per share (in dollars per share)					$ 25

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		8 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	$ 451,194,000				$ 451,194,000		$ 349,518,000
Payment-in-kind interest income	573,000	$ 211,000	$ 450,000		1,647,000
Dividend income	17,000	0	0		115,000
Other income	100,000	446,000	446,000		131,000
Offering costs	326,000	225,000	375,000		660,000
Noninterest expense offering cost	187,000	$ 78,000	$ 118,000	[1]	468,000	$ 118,000
Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	$ 67,603,000				$ 67,603,000		$ 70,361,000
Investment Type Concentration Risk | Investments At Fair Value | Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage					15.17%		20.13%
[1]Period from February 8, 2022 (inception) through September 30, 2022.

FAIR VALUE MEASUREMENTS - Sched

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurements of Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 451,194	$ 349,518
First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	341,698	251,371
Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	94,751	93,809
Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	9,328	4,338
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,417
Second Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	45,206	30,906
Mezzanine Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	49,545	62,903
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,417	0
Level 1 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,417
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,383	1,704
Level 2 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,383	1,704
Level 2 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	414,394	347,814
Level 3 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	310,315	249,667
Level 3 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	94,751	93,809
Level 3 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	9,328	$ 4,338
Level 3 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 0

FAIR VALUE MEASUREMENTS - Sch_2

FAIR VALUE MEASUREMENTS - Schedule of Reconciliation of the Beginning and Ending Balances for Investments (Details) - USD ($) $ in Thousands	3 Months Ended		8 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2023
Total
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 389,586	$ 293,795	$ 0	$ 347,814
Purchase of investments	36,909	30,426	351,892	90,438
Proceeds from principal repayments and sales of investments	(11,251)	(1,102)	(27,692)	(24,645)
Payment-in-kind interest	447	409	409	1,521
Amortization of premium/accretion of discount, net	114	134	325	597
Transfers out of Level 3	(1,802)
Ending balance	414,394	322,408	322,408	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	335	(1,257)	(2,262)	(1,464)
Total | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	75	3	(264)	692
Total | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	316	(1,257)	(2,262)	(2,023)
First Lien Term Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	294,555	197,343	0	249,668
Purchase of investments	28,637	25,868	231,983	75,150
Proceeds from principal repayments and sales of investments	(11,251)	(1,102)	(8,692)	(14,041)
Payment-in-kind interest	0	0	0	0
Amortization of premium/accretion of discount, net	67	82	198	412
Transfers out of Level 3	(1,802)
Ending balance	310,315	221,448	221,448	310,315
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	53	(746)	(2,058)	(905)
First Lien Term Loans | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	75	3	17	90
First Lien Term Loans | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	34	(746)	(2,058)	(964)
Subordinated Debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	89,541	94,727	0	93,808
Purchase of investments	4,509	3,556	117,526	9,976
Proceeds from principal repayments and sales of investments	0	0	(19,000)	(10,212)
Payment-in-kind interest	447	409	409	1,521
Amortization of premium/accretion of discount, net	47	52	127	185
Transfers out of Level 3	0
Ending balance	94,751	98,120	98,120	94,751
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	207	(624)	(661)	(514)
Subordinated Debt | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0	(281)	311
Subordinated Debt | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	207	(624)	(661)	(838)
Equity Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	5,490	1,725	0	4,338
Purchase of investments	3,763	1,002	2,383	5,312
Proceeds from principal repayments and sales of investments	0	0	0	(392)
Payment-in-kind interest	0	0	0	0
Amortization of premium/accretion of discount, net	0	0	0	0
Transfers out of Level 3	0
Ending balance	9,328	2,840	2,840	9,328
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	75	113	457	(45)
Equity Investments | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0	0	291
Equity Investments | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 75	$ 113	$ 457	$ (221)

FAIR VALUE MEASUREMENTS - Sch_3

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 410,596,000	$ 346,620,000
First Lien Term Loans | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 258,715,000	$ 228,304,000
First Lien Term Loans | Yield Method | Low | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0613	0.0898
First Lien Term Loans | Yield Method | High | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1950	0.1337
First Lien Term Loans | Yield Method | Weighted Average | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1172	0.1063
First Lien Term Loans | Recent Transaction
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 51,600,000	$ 21,363,000
First Lien Term Loans | Recent Transaction | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.08	98.01
First Lien Term Loans | Recent Transaction | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100	98.08
First Lien Term Loans | Recent Transaction | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	99.06	98.05
Subordinated Debt | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 92,577,000	$ 88,391,000
Subordinated Debt | Yield Method | Low | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1157	0.0888
Subordinated Debt | Yield Method | High | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.2163	0.1794
Subordinated Debt | Yield Method | Weighted Average | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1432	0.1339
Subordinated Debt | Recent Transaction
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 2,174,000	$ 5,418,000
Subordinated Debt | Recent Transaction | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.27	97.58
Subordinated Debt | Recent Transaction | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.31	98.08
Subordinated Debt | Recent Transaction | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.28	97.82
Equity Investments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments valued using recent transactions	$ 3,798,000	$ 1,194,000
Equity Investments | Market Approach
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 5,530,000
Equity Investments | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.50
Equity Investments | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	19.50
Equity Investments | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	10.18
Equity Investments | Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value		$ 3,144,000
Equity Investments | Enterprise Value | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		9.25
Equity Investments | Enterprise Value | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.5
Equity Investments | Enterprise Value | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		10.93

RELATED PARTY TRANSACTIONS - Na

RELATED PARTY TRANSACTIONS - Narrative (Details)

3 Months Ended

8 Months Ended

9 Months Ended

Jan. 10, 2023

Aug. 03, 2022

Aug. 02, 2022

Jun. 03, 2022 USD ($)

Mar. 31, 2022 USD ($)

Sep. 30, 2023 USD ($) member

Sep. 30, 2022 USD ($)

Mar. 31, 2022

Sep. 30, 2022 USD ($)

Sep. 30, 2023 USD ($) member part

Dec. 31, 2022 USD ($)

Related Party Transaction [Line Items]

Management fees

$ 547,000

$ 0

$ 0

[1]

$ 712,000

Income based incentive fees

1,219,000

0

0

[1]

1,592,000

Administration fees

$ 124,000

74,000

149,000

[1]

$ 362,000

Number of board members | member

7

7

Number of independent directors | member

4

4

Directors' fees

$ 128,000

128,000

257,000

[1]

$ 380,000

Directors’ fees payable

128,000

128,000

$ 128,000

Accounts payable and accrued expenses

1,924,000

1,924,000

1,386,000

Affiliated Entity

Related Party Transaction [Line Items]

Income based incentive fees

1,219,000

0

0

1,592,000

Income based incentive fee payable

0

$ 0

Affiliated Entity | TIAA

Related Party Transaction [Line Items]

Capital commitments

$ 263,500,000

Interest rate, stated percentage

4%

4%

Debt instrument, periodic payment, principal

$ 32,731,000

Debt instrument, periodic payment, interest

$ 226,000

Investment Advisory Agreements | Affiliated Entity

Related Party Transaction [Line Items]

Related party transaction, period of written notice

120 days

60 days

Related party transaction, initial term

2 years

Related party transaction period of written notice by fund

60 days

Number of components | part

2

Base Management Fee | Affiliated Entity

Related Party Transaction [Line Items]

Base management fee percentage

0.75%

Management fees

547,000

0

0

$ 712,000

Management fees payable

0

0

Quarterly Hurdle Rate | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

1.50%

Annualized Hurdle Rate | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

6%

Pre-Incentive Fee Net Investment Income below catch-up threshold | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

100%

Quarterly Catch-Up Threshold | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

1.76%

Investment Advisory Agreement - Incentive Rate, Annualized Catch-Up Threshold | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

7.06%

Pre-Incentive Fee Net Investment Income Exceeds Catch-Up Threshold | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

15%

Realized Capital Gains | Affiliated Entity

Related Party Transaction [Line Items]

Incentive fee percentage

15%

Sub-Advisory Agreement | Affiliated Entity

Related Party Transaction [Line Items]

Related party transaction, period of written notice

120 days

60 days

Related party transaction, initial term

2 years

Management and service fees, rate

0.375%

Administrative Agreement | Affiliated Entity

Related Party Transaction [Line Items]

Administration fees

124,000

$ 74,000

$ 149,000

362,000

Administration fees payable

505,000

505,000

246,000

Intermediary Manager Agreement | Affiliated Entity

Related Party Transaction [Line Items]

Related party transaction period of written notice by fund

60 days

Percentage of shareholder servicing fees, proceeds from sale of such share

10%

10%

Percentage of underwriting compensation, net

10%

10%

Percentage of expense, proceeds from offering

15%

15%

Intermediary Manager Agreement | Affiliated Entity | Class S Common Shares

Related Party Transaction [Line Items]

Shareholder servicing fees monthly, annual rate

0.85%

0.85%

Intermediary Manager Agreement | Affiliated Entity | Class D Common Shares

Related Party Transaction [Line Items]

Shareholder servicing fees monthly, annual rate

0.25%

0.25%

Expense Support Agreement

Related Party Transaction [Line Items]

Related party transaction, expense payment period

45 days

Expense Support Agreement | Affiliated Entity

Related Party Transaction [Line Items]

Related party transaction, period of reimbursement payment

3 years

Advisor And Administrator | Affiliated Entity

Related Party Transaction [Line Items]

Accounts payable and accrued expenses

$ 344,000

$ 344,000

$ 231,000

[1]Period from February 8, 2022 (inception) through September 30, 2022.

RELATED PARTY TRANSACTIONS - Sc

RELATED PARTY TRANSACTIONS - Schedule of Expenses Reimbursed by the Adviser (Details) - Expense Support Agreement - Affiliated Entity - USD ($) $ in Thousands	3 Months Ended							21 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023
Related Party Transaction [Line Items]
Expense Payments by Adviser	$ 327	$ 113	$ 198	$ 176	$ 379	$ 677	$ 983	$ 2,853
Reimbursement Payments to Adviser	0	0	0	0	0	0	0	0
Unreimbursed Expense Payments	$ 327	$ 113	$ 198	$ 176	$ 379	$ 677	$ 983	$ 2,853

SECURED BORROWINGS - Narrative

SECURED BORROWINGS - Narrative (Details) - USD ($)			9 Months Ended
	Oct. 04, 2022	Oct. 03, 2022	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Asset coverage ratio			350.22%	267.94%
Maximum facility amount available			$ 250,000,000	$ 250,000,000
Bank of America Credit Facility | Secured Borrowings | Credit Facility
Debt Instrument [Line Items]
Maximum facility amount available	$ 250,000,000	$ 200,000,000	$ 250,000,000	$ 250,000,000
Bank of America Credit Facility | Secured Borrowings | Secured Overnight Financing Rate (SOFR) | Credit Facility
Debt Instrument [Line Items]
Percentage of interest rate	2.15%	2%	2.40%
Bank of America Credit Facility | Secured Borrowings | Secured Overnight Financing Rate (SOFR) | Credit Facility | One Year After Closing Date
Debt Instrument [Line Items]
Percentage of interest rate	2.40%

SECURED BORROWINGS - Schedule o

SECURED BORROWINGS - Schedule of Borrowings (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Oct. 04, 2022	Oct. 03, 2022
Debt Instrument [Line Items]
Total Commitment	$ 250,000,000	$ 250,000,000
Borrowings Outstanding	120,750,000	155,000,000
Unused Portion	129,250,000	95,000,000
Amount Available	103,112,000	81,855,000
Bank of America Credit Facility | Secured Borrowings | Credit Facility
Debt Instrument [Line Items]
Total Commitment	250,000,000	250,000,000	$ 250,000,000	$ 200,000,000
Borrowings Outstanding	120,750,000	155,000,000
Unused Portion	129,250,000	95,000,000
Amount Available	$ 103,112,000	$ 81,855,000

SECURED BORROWINGS - Schedule_2

SECURED BORROWINGS - Schedule of Components of Interest Expense and Debt Financing Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023
Debt Disclosure [Abstract]
Borrowing interest expense	$ 2,469	$ 1,189	$ 1,654		$ 7,238
Unused fees	124	117	203		351
Amortization of Debt Issuance Costs	44	19	35		122
Total interest and debt financing expenses	$ 2,637	$ 1,325	$ 1,892	[1]	$ 7,711
Average interest rate	8.02%	4.67%	4.01%		7.57%
Average daily borrowings	$ 128,192	$ 110,788	$ 102,442		$ 133,903
Deferred financing costs were designated for reimbursement	$ 0	$ 373	$ 373		$ 2
[1]Period from February 8, 2022 (inception) through September 30, 2022.

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Schedule of Unfunded Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 29,597	$ 21,202
Investment, Identifier [Axis]: ADPD Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,919	2,149
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	26	0
Investment, Identifier [Axis]: Acclaim MidCo
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	891	0
Investment, Identifier [Axis]: COP Exterminators
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	503	0
Investment, Identifier [Axis]: Chroma Color Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	381	0
Investment, Identifier [Axis]: Evergreen Services Group, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	267
Investment, Identifier [Axis]: Health Management Associates
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	415	0
Investment, Identifier [Axis]: Heartland Veterinary Partners, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,210	5,000
Investment, Identifier [Axis]: INS Intermediate
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,139	0
Investment, Identifier [Axis]: ISG Merger Sub, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	766	1,282
Investment, Identifier [Axis]: ITSavvy, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	36	480
Investment, Identifier [Axis]: Impact Parent Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,832	0
Investment, Identifier [Axis]: Infobase Acquisition, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	122	122
Investment, Identifier [Axis]: KL Bronco Acquisition, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	599	599
Investment, Identifier [Axis]: KRIV Acquisition
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	779	0
Investment, Identifier [Axis]: Kenco Group, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	850	850
Investment, Identifier [Axis]: Keng Acquisition
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,041	0
Investment, Identifier [Axis]: LMI Consulting, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2	0
Investment, Identifier [Axis]: Legacy Service Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	479	0
Investment, Identifier [Axis]: MEI Rigging & Crating
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	501	0
Investment, Identifier [Axis]: Omnia Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	129	0
Investment, Identifier [Axis]: Orion Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,571	0
Investment, Identifier [Axis]: Ovation Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	470	0
Investment, Identifier [Axis]: Palmetto AcquisitionCo
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,217	0
Investment, Identifier [Axis]: Patriot Growth Insurance Service
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,091	5,568
Investment, Identifier [Axis]: Perennial Services
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,319	0
Investment, Identifier [Axis]: Pinnacle Supply Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,455	0
Investment, Identifier [Axis]: RTH
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	323	0
Investment, Identifier [Axis]: Randys Holdings, Inc
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,332	1,332
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	386	735
Investment, Identifier [Axis]: Transit Buyer LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,157	0
Investment, Identifier [Axis]: Trilon Group, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	363
Investment, Identifier [Axis]: Victors CCC Buyer LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	560	560
Investment, Identifier [Axis]: WSB Engineering Holdings
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,096	0
Investment, Identifier [Axis]: Wellspring Pharmaceutical
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 0	$ 1,895

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Cash	$ 6,344	$ 65,785
Unused Portion	129,250	$ 95,000
Unused Portion Under the Bank of America Credit Facility
Debt Instrument [Line Items]
Unused Portion	$ 103,112

NET ASSETS - Narrative (Details

NET ASSETS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			8 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 30, 2022	Sep. 30, 2022	[1]	Sep. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Class of Stock [Line Items]
Net proceeds received			$ 1		$ 42,690
Common shares repurchased (in shares)					0
Maximum number of shares to be repurchased, percent					5%
Common stock market price percent of NAV, threshold					98%
Due to transfer agent					$ 1,145	$ 0
Class I Common Shares
Class of Stock [Line Items]
Issuance of shares (in shares)					1,735,030
Net proceeds received					$ 42,690
Common shares repurchased (in shares)					0
Class S Common Shares
Class of Stock [Line Items]
Shares, issued (in shares)					0
Class D Common Shares
Class of Stock [Line Items]
Shares, issued (in shares)					0
TIAA
Class of Stock [Line Items]
Portfolio investments to the fund amount							$ 296,231
Share repurchase program, percentage of outstanding shares offered to repurchase, NAV					1.67%
TIAA | Class I Common Shares
Class of Stock [Line Items]
Purchased and sold shares (in share)		40
Issuance Price per share (in dollars per share)		$ 25
Issuance of shares (in shares)	10,540,000
Shares issued price per share (in dollars per share)							$ 25
[1]Period from February 8, 2022 (inception) through September 30, 2022.

NET ASSETS - Schedule of Fund's

NET ASSETS - Schedule of Fund's Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Thousands														1 Months Ended
	Sep. 29, 2023	Aug. 23, 2023	Jul. 28, 2023	Jun. 28, 2023	May 25, 2023	Apr. 28, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022
Class of Stock [Line Items]
Gross Distribution														$ 0.15	$ 0.15	$ 0.15	$ 0.14	$ 0.14	$ 0.14
Regular Dividend
Class of Stock [Line Items]
Gross Distribution		$ 0.25	$ 0.25							$ 0.19
Supplemental Dividend
Class of Stock [Line Items]
Gross Distribution										0.105
Special Dividend
Class of Stock [Line Items]
Gross Distribution		0.020	0.020
Class I Common Shares
Class of Stock [Line Items]
Gross Distribution	$ 0.250	$ 0.270	$ 0.270	$ 0.240	$ 0.240	$ 0.240	$ 0.230	$ 0.200	$ 0.200	$ 0.295	$ 0.190	$ 0.180	$ 0.870
Distribution Amount	$ 3,070	$ 3,133	$ 3,081	$ 2,605	$ 2,530	$ 2,530	$ 2,424	$ 2,108	$ 2,108	$ 3,109	$ 2,003	$ 1,897	$ 9,170

NET ASSETS - Schedule of Shares

NET ASSETS - Schedule of Shares Issued Pursuant to the Distribution Reinvestment Plan (Details) - shares	Sep. 28, 2023	Aug. 28, 2023	Jul. 28, 2023
Class I Common Shares
Class of Stock [Line Items]
Shares, issued (in shares)	2,316	1,426	573

CONSOLIDATED FINANCIAL HIGHLI_3

CONSOLIDATED FINANCIAL HIGHLIGHTS (Details) - USD ($) $ / shares in Units, $ in Thousands	8 Months Ended		9 Months Ended
	Sep. 30, 2022		Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Feb. 07, 2022	[1]
Per share data:
Net asset value at beginning of period (in dollars per share)	$ 0		$ 24.70
Net investment income (loss) (in dollars per share)	0.99		2.18
Net realized gains (losses) (in dollars per share)	(0.02)		0.06
Net change in unrealized appreciation (depreciation) (in dollars per share)	(0.22)		(0.18)
Net increase (decrease) in net assets resulting from operations (in dollars per share)	0.75		2.06
Shareholder distributions from income (in dollars per share)	(0.87)		(2.14)
Issuance of common shares (in dollars per share)	25		0
Other (in dollars per share)	0		(0.01)
Net asset value at end of period (in dollars per share)	$ 24.88		$ 24.61
Supplemental Data:
Net assets at end of period	$ 262,221	[1]	$ 302,138	$ 267,280	$ 260,301	$ 267,303	$ 0
Shares outstanding at end of period (in shares)	10,540,040		12,279,386
Total return	2.93%		8.63%
Ratio to average net assets:
Ratio of net expenses to average net assets	1.82%		4.73%
Ratio of net investment income (loss) to average net assets	6.17%		11.75%
Portfolio turnover rate	9.10%		6.36%
Asset coverage ratio	309.78%		350.22%
Ratio of total expenses to average net assets	2.43%		6.48%
Effect of expense support to average net assets ratio	(0.61%)		(0.27%)
Effect of waived management fees	0%		(0.45%)
Effect of waived incentive fees	0%		(1.03%)
Ratio of interest and debt financing expenses to average net assets	1.11%		3.78%
[1]Period from February 8, 2022 (inception) through September 30, 2022.

SUBSEQUENT EVENTS - Schedule of

SUBSEQUENT EVENTS - Schedule of Aggregate Distributions Declared for Each Class of Common Share (Details) - $ / shares															1 Months Ended
	Oct. 27, 2023	Sep. 29, 2023	Aug. 23, 2023	Jul. 28, 2023	Jun. 28, 2023	May 25, 2023	Apr. 28, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022
Subsequent Event [Line Items]
Gross Distribution															$ 0.15	$ 0.15	$ 0.15	$ 0.14	$ 0.14	$ 0.14
Class I Common Shares
Subsequent Event [Line Items]
Gross Distribution		$ 0.250	$ 0.270	$ 0.270	$ 0.240	$ 0.240	$ 0.240	$ 0.230	$ 0.200	$ 0.200	$ 0.295	$ 0.190	$ 0.180	$ 0.870
Class I Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	$ 0.250
Shareholder Servicing Fee	0
Gross Distribution	0.250
Class S Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	0.250
Shareholder Servicing Fee	0.017
Gross Distribution	0.233
Class D Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	0.250
Shareholder Servicing Fee	0.005
Gross Distribution	$ 0.245

SUBSEQUENT EVENTS - Narrative (

SUBSEQUENT EVENTS - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended
	Oct. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Feb. 07, 2022
Subsequent Event [Line Items]
Net asset value per share (in dollars per share)		$ 24.61	$ 24.70	$ 24.88	$ 0
Subsequent Event
Subsequent Event [Line Items]
Net proceeds received	$ 342.4
Net asset value per share (in dollars per share)	$ 24.61